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Composition and features of microbiota 
Intestinal microbiota is defined as a distinct and highly variable composition of 
symbiotic microorganisms that live in the human gut. It is responsible of many 
functions such as to provide nutrients to the host and, at the same time, contribute 
to the maintenance of health status. Qualitative and quantitative alterations of gut 
microbiota could also lead to many diseases at gastrointestinal and systemic levels 
[1] 
The human gastrointestinal tract is composed of approximately 1011-12 cells per ml 
(mainly anaerobic microorganisms), a quantity ten times higher than total number 
of cells of the human body [2]. However, the distribution and the concentration of 
bacteria change along the gastrointestinal tract due to the presence of cells 
belonging to the human immune system, to enzymes, to concentration of bile 
acids, pH and redox potential that determine different habitats and can promote 
the growth of different bacterial species [3]. 
Although the knowledge on the microbiota composition is still largely incomplete 
for intrinsic difficulty of determination and extreme variety of components, it’s 
well known that the dominant bacteria in adult humans belong to a restricted 
number of phyla: mostly Firmicutes and Bacteroidetes, and to a lesser extent 
Actinobacteria and Proteobacteria and Verrucomicrobia [4]. The Firmicutes are 
Gram-positive, facultative or obligate anaerobic, that can produce endospores and 
are present in various sections of the human gut. This phylum includes many 
genres including Lactobacillus, Enterococcus and bacteria belonging to the class 
of Clostridia. The Bacteroidetes are Gram-negative, asporogenous, obligate 
anaerobic, and include Prevotella and Bacteroides. The Proteobacteria are Gram-
negative, facultative anaerobic, including a number of pathogens such as 
Salmonella, Vibrio, Helicobacter, Yersinia and Escherichia. Finally the 
Actinobacteria are Gram-positive anaerobic, including Bifidobacterium. 
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In the oral cavity, there is a high concentration of bacteria, while in the stomach, 
due to acid pH, the concentration is low and few species are able to grow, 
especially Lactobacilli, Streptococci and yeasts. A similar situation can also be 
observed in the duodenum: the acid pH of bile prevents the growth of most 
bacteria and transit time, reduced by luminal contents, prevents a stable 
colonization. At ileum level, a gradual increase in density microbial is observed 
up to the high concentrations in colon tract (1011-12 cells / ml) due to positive 
environmental conditions: slow transit, suitable pH, available nutrients for 
bacteria. 
At birth, the intestine is essentially sterile and colonization by bacteria depends on 
the kinds of birth and feeding. During a normal birth, the baby is exposed to the 
vaginal and faecal flora of the mother, while in case of caesarean section the first 
contact is usually with breastfeeding [5,6]. Especially breastfed babies develop a 
microbial composition dominated by Bifidobacterium [7], while bottle-fed have a 
lower percentage [8]. All these aspects determine the final composition of the 
mature microbiota. Later, introducing solid food in children's diets, the microbiota 
grows and evolves until the composition becomes similar to adult’s one [9]. 
Once adult, microbiota reaches a well-defined composition, with individual 
variability, and remains relatively stable over time [10]. Even after a change of 
diet or short-term antibiotic therapy, composition returns to its initial status due to 
community resilience [11,12]. 
A characterization of the mature microbiota shows that, despite the inter-
individual differences represented by a group of bacteria called auxiliary 
component, certain bacterial species are constantly present constituting a real 
"core" [11,13] However, many factors can influence the composition, including 
psychological and genetic factors [14]. Moreover, the diet plays a very important 
role. Several studies confirm that changing the amount or type of carbohydrates 
for more than four weeks occur deep and quick changes in the composition of the 
intestinal microbiota [11,15]. A further confirmation comes from the comparison 
of the intestinal microbial community among African populations, with high 
vegetable carbohydrates consume, and populations of the EU or the US diets, 
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richer in protein. Children in Africa have a higher amount of Bacteroidetes (73%) 
than children with a number of EU Bacteroidetes 27% and 51% of Firmicutes. In 
addition, the species of Bacteroidetes dominant in the African, and absent in 
others, belongs to the genera Prevotella and Xylanibacter, responsible of the 
fermentation of xylans and other components of plant fibre [16]. 
Studies conducted on the microbiota provide, in most cases, a use of human 
faeces, in order to obtain a composition intestinal microbial closer to real one; it 
represents also the simplest technique and easy access from sampling. Studies 




In balanced diet, about 40 g of carbohydrates reach daily the colon without any 
metabolism by human enzymes. Most of them are represented by resistant starch 
(RS), non-starch polysaccharides (NSP) and oligosaccharides, although a small 
part of the mono- and disaccharides can reach the colon as well [4]. 
The microbiota is able to degrade some non-digestible food compounds and the 
endogenous mucus produced by epithelium; they represent their main source of 
energy in the colon. The fermentation of these carbohydrates leads to the 
production of important and useful molecules for the guest, the Short Chain Fatty 
Acids (SCFAs), mainly acetate, propionate and butyrate in the ratio 3: 1: 1 [17]. 
SCFAs provides multiple functions, for example they are energetic source, 
promote cell differentiation and regulate the immune system of the host [18]. 
SCFAs also promote the release of hormones as GlucagoneLikePeptide1 - GPL1 
from intestinal cells, leading to an increased release of insulin, a reduction in the 
release of glucagon, gastric slowdown and satiety feeling, reduction of gastric and 
pancreatic secretion and reduction absorption of nutrients [19]. In particular, the 
butyrate is the main source of energy for the colonocytes, has an anti-
inflammatory action, inhibits cell proliferation, and has been observed its ability 
in vitro to stimulate the differentiation of epithelial neoplastic cell lines in addition 
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to promoting the reversion from the neoplastic phenotype in non-neoplastic 
[20,21]. Propionate is transported to the liver and participates in gluconeogenesis; 
in the liver it also plays a role in the inhibition of the cholesterol’s biosynthesis 
[22]. Acetate, once into the systemic circulation, mainly reaches the liver and 
muscle tissue where it is used for lipogenesis [23]. 
The amount of SCFA varies along the gastrointestinal tract, depending on the 
environmental conditions and the availability of nutrients. For example, in cecum 
and ascendant colon, fermentation it is very intense and provides a high SCFA 
concentration due to acidic pH values (5-6) and to the presence of bacteria with 
strong saccharolytic activity. On the contrary, at the level of the left colon and the 
distal one, it proteolytic activity is lower due to the lower amount of available 
substrate and a pH close to neutral. In this case, main metabolism is the anaerobic, 
in particular of peptides and proteins with the production of SCFAs, but with 
production of isobutyrate, 2-methylbutyrate and isovalerate (Branched Chain 
Fatty Acids, BFCA) [24]. 
The main source of protein that reaches the colon is derived from the diet, such as 
elastin and collagen, but also from epithelial cells, lysed bacterial and pancreatic 
enzymes. Instead of carbohydrate fermentation, the microbial metabolism of 
proteins and peptides leads to the formation of potentially toxic metabolites, able 
to contribute to the development of intestinal diseases or tumours, such as 
ammonia, amines, phenols, thiols and indoles [25]. 
Some bacterial species, especially those belonging to the genera Bacteroides, 
Clostridium, Bifidobacterium and Lactobacillus are involved in deconjugation of 
bile salts and their reabsorption in the colon [26]. Finally, the intestinal microbiota 
is responsible for the synthesis of vitamins (especially in the group B) such as 
thiamine, riboflavin, pyridoxine and niacin, and contributes to the absorption of 





Figure 1: Microbiota metabolites from carbohydrates and protein fermentation [4] 
 
Microbiota and immune system 
Microbiota contributes to the development and regulation of the intestinal immune 
system as demonstrated by several studies on germ-free animals [28,29]. 
Furthermore, immune response due to microbiota can prevent the development of 
inflammatory states, which would cause an alteration in the composition with 
adverse consequences for human health. There is therefore a host-microbiota 
symbiosis necessary for intestinal homeostasis. On the other hand it was shown 
that dysbiosis of intestinal bacterial flora contributes to cause the onset of 
pathological states such as diabetes, allergies, and even obesity [30]. 
In the gastrointestinal tract are numerous aggregates of lymphoid cells as 
pharyngeal tonsils, Peyer's patches (PPs), isolated lymphoid follicles (ILFS) and 
mesenteric lymph nodes (MLNs) which together constitute a system called GALT 
(Gut Associated Lymphoid Tissue) [31]. Peyer's patches are located in the mucosa 
and submucosa of the small intestine and consist mainly of type B lymphocytes, 
able to secrete antibodies (mostly IgA) that are transported in the lumen of the 
intestine, where they bind to antigens and trigger other components of the immune 
system [32]. The isolated lymphoid follicles (ILFs) contains M cells, which 
improve the uptake of antigens and microbes from the lumen to the underlying 
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lymphoid tissues [33]. The ILFs are similar to the Peyer's patches for both function 
and structure, but they are smaller and are also found in the large intestine [34]. 
Intestinal epithelium consists of a single cell layer that prevents the invasion of 
pathogens, acting as a physical barrier. A layer of mucus separates the lumen of 
the intestine from the epithelial surface, avoiding direct contact of pathogenic 
microorganisms, and produces antimicrobial peptides such as C-type lectins 3β/γ 
(REGIIIβ and REGIIIγ). These cells can express numerous receptors that 
contribute to the organism's defence. The pattern recognition receptors (PRRs) 
(i.e. Toll-like receptor) have a crucial role in immunity, since they are able to 
recognize molecular structures of pathogens and start the reactions that lead to the 
innate immune response [31]. In addition, the intraepithelial lymphocytes (IELS) 
are part of the GALT and consist mainly of T cells CD8 positive. These cells help 
in preserving the integrity of the epithelial surfaces damaged, promoting the 
secretion of the "keratinocyte growth factor" (KGF), but on the other hand are able 
to produce interferon-gamma, favouring the development of inflammatory 
diseases [30,35,36]. 
 
Figure 2: Interaction among intestinal microbiota and immune system [30] 
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Studies on germ-free animal (GF) reveal that microbiota contributes to the 
development of the GALT and promotes the barrier function of the intestinal 
epithelium. In rat GF, Peyer's patches are less active and less developed [37] and 
there is a lower amount of IELS than animals non GF [38,39]. The mucosal layer 
is significantly thinner as well. However the exposure of GF animals to intestinal 
bacteria leads to the restoration of an appropriate organization of the intestinal 
immune system [40] and a proper thickness of the layer of mucus, due to bacterial 
products such as lipopolysaccharide or peptidoglycan [41]. The lack of 
antimicrobial peptides and REGIIIβ - REGIIIγ leads to increased susceptibility of 
mice to attack by pathogens [42]. These observations indicate that the microbiota 
induces the development of lymphoid tissue through a detection innate system 
[30]. 
Among the products of microbial fermentation, those contributing mostly to 
organism’s defence are the SCFA such as acetate, propionate and butyrate. 
Bifidobacteria inhibit the transport of toxins produced by Escherichia Coli from 
the intestinal lumen to the blood producing acetate [43]. Moreover, most of the 
SCFA bind to receptor coupled with protein G GPR43 that has a big role in 
inflammatory responses [44]. Mice without this receptor or GF mice that express 
it have severe inflammatory responses resulting in disease states such as colitis. 
In particular, butyrate is able to reduce the production of proinflammatory 
molecules by the intestinal cells, such as cytokine MCP-1, IL-6 and IFN-γ and 
together with the propionate decreases nitric oxide production by neutrophils and 
tumour necrosis factor. The production of SCFA leads to an anti-inflammatory 
effect, which has a positive role in the prevention of chronic inflammatory 
diseases such as metabolic syndrome, obesity and contributes in the slowing of 
aging [45]. 
The T-helper lymphocytes 17 are found in high concentrations in the lamina 
propria and have a role in defence and development of autoimmune diseases by 
producing proinflammatory cytokines IL-17 and IL-22. The microbiota appears 
to have an important role in their expression and in the GF mice the number of 
these cells is extremely small [46]. 
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In addition to the active role in development and maintenance of innate and 
acquired immunity, microbiota contrasts the growth of pathogens by competing 
for substrates. A kind of tolerance by the host against him was observed, 
maintaining the ability to fight pathogens. The interaction between the host and 
the bacterial microflora is not yet fully clarified, but some bacteria (such as 
Bacteroides fragilis) are able to survive through their ability of modulating their 
antigenicity surface. The microbiota is capable of forming a wide variety of 
combinations of surface polysaccharides, escaping immuno-surveillance of the 
host [47]. 
 
Probiotics and prebiotics 
The intake of probiotics and prebiotics can influence the composition of the 
intestinal microbiota, increasing the growth of bacteria with beneficial effects on 
human health [48], or could have positive effect on metabolic disorders as obesity 
[49]. Probiotics are defined as "live microorganisms which when administered in 
adequate amounts confer a health benefit on the host" (FAO/WHO, 2002). 
Interesting probiotic bacteria belong to genera Lactobacillus and Bifidobacterium 
and are widely used in fermented foods [50]. These bacteria showed the ability to 
modulate the signalling pathways of intestinal epithelial secretions, to influence 
cytokines and IgA antibodies and to increase the production of mucin by 
improving the functionality of epithelial barrier [51]. 
Prebiotics are defined as "non-digestible food ingredients that beneficially affect 
the host by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria in the colon, thus improving host health" [52]. Prebiotics avoid 
digestion by enzymes in the upper gastrointestinal tract and, at the colon level, 
affect the growth of specific microbial populations and the production of SCFA, 
influencing the intestinal functionality [53]. More studied prebiotics are fructo-
oligosaccharides (FOS), galacto-oligosaccharides (GOS) and inulin, which are 
selectively utilized by Bifidobacteria and Lactobacilli [54]. 
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Finally, the symbionts are combinations of probiotics and prebiotics useful to 
provide a synergic beneficial effect for health that cannot be obtained using the 
two components separated. 
 
In vitro gastrointestinal simulation technology SHIME® 
In order to understand deeply the activity and balance of gut microbiota, many 
different in vitro models were developed so far. The most common and easy way 
is using static models as batch culture fermentation. Lactobacillus and 
Bifidobacteria are extensively employed to study different aspects of microbial 
response to diet, and in particular to phenolic compounds [55]. Batch cultures are 
a suitable technique to carry out preliminary studies on stability of both bacteria 
and polyphenols, however more complex system are necessary for a more 
complete knowledge [56]. In addition to short-term, static batch culture models, 
other systems were designed, operating in continuous and reproducing the whole 
microbial community [57–59]. 
The SHIME® (Simulator of Human Intestinal Microbial Ecosystem) is a validated 
and dynamic in vitro model of complete gastrointestinal tract, useful for studying 
chemical-physical, enzymatic and microbial parameters. A careful control of 
environmental parameters allows to obtaining a stable and complex microbial 
community, very similar to the composition of different regions of the human 
gastrointestinal tract. The system consists of a series of vessel where it is 





Figure 3 – Basic design of SHIME® system [www.prodigest.eu] 
Depending on the type of experiment is possible to choose among three 
configurations representing the colon: 
• 1 colon region (pH = 6.15-6.4, V = 500 mL) [60] 
• 2 colon regions: proximal (pH = 5.6-5.9, V = 500 mL) and distal (pH = 6.6-6.9, 
V = 800 mL) [60] 
• 3 colon regions: ascending (pH = 5.6-5.9, V = 500 mL), transverse (pH = 6.15-
6.4, V = 800 mL) and falling (pH = 6.6-6.9; V = 600 mL) [61] 
Vessels are hermetically closed to preserve simulated conditions, and each one 
communicates with the next vessel through tubes and pumping systems. There are 
also additional channels to maintain proper pH value and to access content without 
disturbing the balance. The whole system is treated with N2 to eliminate the air 
and in particular O2 that would affects the optimal conditions. 
The SHIME® is suitable for in vitro studies on different compounds, such as foods, 
botanicals, prebiotics, probiotics, synbiotics or drugs, even with long-term 
treatments, up to 8-10 weeks. 
The information obtained with this system are the production of SCFA and 
ammonia, the evaluation of changes in the microbial community and the definition 
of the metabolic fate of specific compounds, in particular from food matrices. 
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The study can include also any information about the activities of microbial 
adhesion to intestinal mucosa, using the M-SHIME® (Mucus - SHIME®), where 
the conventional configuration of SHIME® is improved by the addition of inert 
compartment covered in mucin. These carriers are replaced every 2-3 days to 
simulate the renewal of the layer of mucus [62]. 
 
Figure 4: Gut simulator M-SHIME® 
Food products 
Dietary supplements and functional foods 
Food supplements consumption is becoming one of most trendy topic. The 
research of “food supplements” in scientific literature provides around 270,000 
results, 19,000 just in 2015. Much attention is focused on beneficial effects of 
supplements [63], in particular on polyphenols, due to their well-known anti-
oxidant activity and several positive effects. 
However, many issues were considered about this topic. The most important is 
about the control of polyphenols content in botanicals. The European Commission 
promoted studies to improve guidelines and knowledge [64], while a survey on 




Once defined supplements content, it is important to understand the fate of main 
compounds once introduced in the organism. In order to define correct dosages 
for daily intake, different aspects need to be considered, such as in vivo 
metabolism, bioavailability, absorption and elimination, interaction with 
microbial community of gastrointestinal tract [55]. Beneficial or adverse effects 
depend on concentration of each molecule included in food supplements and its 
derivatives. Since big amount of polyphenols arrive at colon level without being 
processed, the main compounds and their metabolites can exert important effects 
on gut balance [66]. Microbial community is also responsible of huge degradation 
of phenolic compounds [67], but further knowledge of this interaction is required 




Food wastes are defined as “any food, and inedible parts of food, removed from 
the food supply chain to be recovered or disposed (including composted, crops 
ploughed in/not harvested, anaerobic digestion, bio-energy production, co-
generation, incineration, disposal to sewer, landfill or discarded to sea)”[68]. The 
sources of wastes are several through the Food Supply Chain (FSC). At farming 
levels, the production of food provide large amount of sub-products, in particular 
part of vegetables with low commercial value. Food processing in another source 
of food waste, including inedible parts and matters affected by the processes. Even 
during the last step, the retail system, big amount of wastes are generated [69]. 
The consequences on environment of generating high volumes of food waste are 
several: it can contributes to emission of Green House Gas (GHG) and to depletion 
of natural sources, and has a strong social and economic impacts [70]. 
In 2011 FAO reported that “one-third of the edible parts of food produced for 
human consumption, gets lost or wasted globally, which is about 1.3 billion ton 
per year” [71]. Big discards are also due to an improper treatment of sub-products, 
in particular in agricultural sector and food processing industry. Post-harvesting 
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and processing are responsible of more than 40% of losses, mainly in industrial 
countries [72]. 
In last years, the interest for food waste valorisation increased much. Many by-
products, recovered from different vegetable food, are widely investigated for the 
development of biofuel or bioenergy production processes [73]. Most wastes from 
plants resulted to be good candidate also for recovery of nutraceutical ingredients, 
suitable to be included in dietary supplements or food formulations. Cereals, roots, 
oil crops and fruit/vegetables by-products are all potential sources of bioactive and 
functional compounds [74].One of the main goal for the future is to define 
processes and new techniques to transform wastes in suitable extracts enriched in 
bioactive compounds. 
One of the most investigated food process is the olive oil production. Residues of 
milling process are well-known to own negative properties, such as phytotoxicity, 
pollution of natural waters, affection of aquatic life [75]. Different strategies are 
already evaluated to recover wastewaters and pomace, including physical, 
physicochemical and biological treatments [76–82]. 
At the same time, also pomegranate wastes (seeds and peel) were studied to 
become a source of polyphenols, in particular phenolic acids, flavonoids, tannins 
[83,84]. Even in this case, several kind of extraction are reported to obtain 
maximum yield of main interesting molecules, as ultrasound-assisted extraction, 
highlighting a variability in the results and according with the high content of 
active compounds [85,86]. Recently it has been reported how during the milling 
process the recovery of polyphenols is in olive oil reaches a average of 2%, while 
the largest part of bioactive compounds is discarded with wastes [87]. 
These examples show the possible high valorisation of food by-products. Their 
safety in human use need to be studied deeply for formulation of food supplements 








General features and classification 
Polyphenols constitute a very heterogeneous group of molecules and usually enter 
in the organism through vegetable food. Fruits, vegetables, whole grains and other 
foods and beverages such as tea, chocolate and wine are rich [88]. Diets enrich in 
polyphenols are beneficial to health, and in particular help in the prevention of 
cancer, heart disease and neurodegenerative diseases [88]. These molecules are 
produced by the secondary metabolism of plants, which use them in the processes 
of growth and reproduction, but also as defensive agents. Polyphenols are strong 
antioxidants and in vivo, with vitamins and enzymes, contrast oxidative stress 
caused mainly by an excess of "reactive oxygen species" (ROS). 
From the chemical point of view, polyphenols are characterized by the presence 
of several phenolic groups, associated in structures, more or less complex, 
generally of high molecular weight. To date more than 8000 phenolic structures 
have been identified and are classifiable from the chemical point of view in 
different subclasses. 
 Phenolic acids: non-flavonoids polyphenolic compounds, which can be 
classified into benzoic acid derivatives and derivatives of cinnamic acid. Fruits 
and vegetables contain many free phenolic acids, while in crop and seeds these 
molecules are mainly linked to other molecules. These phenolic acids may be 
hydrolysed by chemical reactions acidic or alkaline, and by enzymes. 
 
Figure 5: Main food phenolic acids: benzoic acids and cinnamic acids [89] 
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  Flavonoids: the basic structure is characterized by two phenolic rings (A and B) 
of 6 carbon atoms, bound to each other through 3 carbon atoms, which are 
arranged linear or form a third oxygenated cyclic ring (C). Flavonoids can be 
further divided, due to variation of the ring C and the number and arrangement 
of hydroxyl, into subgroups such as anthocyanins, flavan-3-ols (also called 
flavanols or catechins), flavones, flavanones and flavonols. Most of the 
flavonoids have the ring B bound to the ring C in position C2, but others, such as 
isoflavones and neoflavonoids, have the ring B linked to the C in position 3 and 
4. These last two categories are present in a few natural sources and are smaller 
subgroups compared to flavonols and flavones. Even if they do not present the 
heterocyclic ring C, chalcones are always classified as flavonoids, and come from 
the degradation of anthocyanins. Proanthocyanidins are traditionally included in 
the class of condensed tannins and are formed by the polymerization of catechin 
and epicatechin (cis configuration), typically found for instance in honey and 
grapeseed. These structures are indicated as aglycones when they do not contain 
glycosidic groups, however most of these compounds are found in nature as 
glycosides. 
• Other polyphenols: some polyphenols have functional groups containing N 
such as capsaicinoids, usually classified as alkaloids and responsible for the 
stinging sensation of hot peppers (Capsicum genus). 
• Other non-flavonoid phenols: other non-flavonoids are considered important 
for human health. Some examples are resveratrol, belonging to stilbenes and 
mainly found in wine, grapes and some berries, ellagic acid and its derivatives, 
present in fruits, pomegranate and walnuts, curcumin, a strong antioxidant 






Figure 6: Structures of main flavonoids. 
 
Polyphenols in olive “pâté” 
Main polyphenols included in the olive “pâté” were already identified as tyrosol, 
hydroxtyrosol, oleuropein aglycone, usually developing during oil mill 
processing, verbascoside and caffeic acid. 
Hydroxytyrosol (3,4-dihydroxyphenolethanol) and tyrosol (4-
hydroxyphenylethanol) are low weight polyphenols and are classified as phenolic 
alcohol. The structure is similar, hydroxytyrosol just have one more hydroxyl 
group. 
 
Figure 7: Hydroxytyrosol (1) and tyrosol (2). 
Different studies confirmed that hydroxytyrosol already showed many positive 
activities on human wellness. It resulted anti-oxidant in human enterocytes, 
contrasting oxidative damages [90], anti-inflammatory for leukotrienes and 
prostaglandins inhibition [91,92] and antimicrobic [93,94]. That molecule should 
be used for cardioprotective and antiatherogenic properties, since it behaves as 
scavenger, reducing the amount of superoxide anions [95] and preventing LDL 
oxidation [96]. Hydroxytyrosol also showed anticancer functions, inhibiting DNA 
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damage peroxynitrite-dependent [97], inducing apoptosis cytochrome C-
dependent [98] and also contrasting the proliferation of cancer cells [99]. Human 
intervention studies are in progress to assess the effects of this small molecule. 
Recently, a human intervention study (IMEDEA Food) was aimed to evaluate the 
detoxifying capacity of hydroxytyrosol and its effects on the expression of phase 
II enzymes involved in detoxification in the liver [100]. 
The verbascoside (or acteoside) is a phenylpropanoid, derived by esterification of 
caffeic acid, and is classified in phenolic acids. 
 
Figure 8: Verbascoside 
In literature, several studies agree on anti-inflammatory, antioxidant, antiviral and 
antifungal activities of this molecules. Verbascoside is an effective antioxidant, 
due to its ability to inhibit LDL oxidation, which have an important role in 
atherosclerosis processes [101]. Verbascoside also showed anti-inflammatory 
activity in test for inhibition of macrophages functionality, involved in 
inflammatory processes [102]. Other studies demonstrated also the action of 
verbascoside on ACE inhibitor enzyme, involved in hypertensive diseases [103]. 
It has positive inotropic and chronotropic effects and is a vasodilator of coronary 
arteries [104].Verbascoside also showed to own antihyperalgesic property in 
treating neuropathic pain in in vivo studies in rats [105]. 
 
Caffeic acid belongs to phenolic acids class (or phenol carboxylic acid) and is a 
metabolite of verbascoside. It derived from 4-hydroxycinnamic acid and its basic 




Figure 9: Caffeic acid 
 
Caffeic acid has antioxidant, due to its ability of reducing oxidative stress [106], 
anti-inflammatory, inhibiting 5-lipoxygenase, antiatherogenic, contrasting the 
LDL oxidation [107] and chemoprotective properties, since it inhibits the 
oxidation of DNA in prostate cells [108]. 
Another group of phenolic substances present in plants belonging to the class of 
Oleaceae, is represented by secoiridoid. Oleuropein is a phenolic monoglucoside 
present at high concentrations in the fruit flesh; it is found in lower quantities as 
aglycone both in oil and mainly in by-products from virgin olive oil production. 
Due to its chemical structure, these derivatives are sources of hydroxytyrosol that 
can be easily released after hydrolysis of the ester bond, a typical process that 
occurs even in the extra virgin olive oils during their shelf life. 
 
Figure 10: Oleuropein 
 
Polyphenols in pomegranate mesocarp 
The phenolic compounds present in greatest amount in the mesocarp of 
pomegranate (Punica granatum fruit), are hydrolysable tannins and, in particular, 
gallic acid and ellagic acid esters. Numerous combinations of monomers are 
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possible, which determine the formation of a high number of different structures. 
These are divided into gallotannins (esters of gallic acid and glucose) and 
ellagitannins (hexahydroxydiphenic and esters of glucose).  
 
Figure 11: Main polyphenols in pomegranate mesocarp. 
 
Ellagic acid has antioxidant, anticarcinogenic and antiatherogenic properties [109] 
and there are many studies on in vivo activity of pomegranate phenols. 
Urolithins derivate from the metabolization of ellagitannins (including 
punicalagins) and ellagic acid by the human intestinal microbiota, after the loss of 
a lactone ring of ellagic acid and subsequent removal of the hydroxyl groups 
[110,111]. Despite punicalagins showed a strong antioxidant activity in vitro, they 
are extensively metabolized by gut microbiota into these derivatives, which show 
a rather insignificant antioxidant capacity [112]. 
 
Figure 12: Chemical structure of ellagic acid, urolithins D, Uro-C, Uro-A e Uro-B. Arrows 




Urolithins were found in plasma, urine and tissues in human and in many animals 
(including pigs, rats, mice) after the intake of foods containing ellagitannins as 
pomegranate, strawberries, raspberries and nuts [113] and are recognized as in 
vivo markers of the absorption of this type of tannins. 
Several in vitro and in vivo studies showed the variety of biological activities 
attributed to urolithins (mainly urolithin A) such as anti-cancer properties in  
prostate cancer [114], anti-inflammatory in colon inflammation the [115], and 
estrogenic / antiestrogenic activities [116]. 
 
Polyphenols in Vineatrol® 30 
Vineatrol® 30 is obtained from grape vine of Vitis vinifera. Generally extracts of 
Vitis vinifera, leaves and fruits, contain several polyphenolic molecules, such as 
anthocyanins, catechins, flavonoids and stilbenes. Monomers and dimers of 
resveratrol belong to latter class and are more abundant in leaves and grapes 
contaminated with fungal infections. In fact, these molecules are recognized as 
factors of defence products in response to certain pests. 
 
Figure 13: Trans-resveratrol 
Stilbenes are photosensitive molecules and the geometry of the double bond in 
these molecules depends on the conditions of plant growth: little light promotes 
the formation of trans isomer, while the growth in a well-lit place allows the cis 
one. These phenols are present in particular in grapes skins, as glycosylated form, 
but also in leaves and petioles. Dimeric forms of resveratrol, ε-viniferin and δ-




Figure 14: trans-ε-viniferin 
 
Resveratrol is also found in a wide variety of foods and plants including the red 
wine, peanuts, pistachios and berries [118], even in low quantities (i.e. in wines, 
values are around 15 mg / L, while the other phenols reach 1 g / L). Numerous 
studies showed different properties of this stilbene. It has anti-inflammatory and 
antioxidant effects [119,120], has the ability to block human platelet aggregation 
and eicosanoid synthesis [121,122], has an agonistic effect on the estrogen 
receptors [123] and inhibitory effects on enzymatic activity of COX-2 [124]. Also 
it showed beneficial effects on the health and survival of mice subjected to a 
highly caloric diet [125]. Moreover, resveratrol may act as chemopreventive agent 
[126], although some data in vivo and in vitro are contradictory [127,128]. 
Other molecules present in Vineatrol® 30 are mostly oligomers or hydroxylated 
derivatives of resveratrol: ampelopsin A, hopeaphenol, trans-piceatannol, 1r-2-
viniferin (vitisin A), miyabenol C, r-viniferin (vitisin B) and iso-trans-ε-viniferin. 




Interaction among polyphenols and microbiota 
Metabolism of polyphenols by intestinal microbiota and absorption 
Once introduced in the organism through oral administration, polyphenols are 
recognized by the body as xenobiotics and their bioavailability is lower than the 
macro and micronutrients. 
Low molecular weight polyphenols, such as monomeric or dimeric structures, are 
absorbed in the small intestine, but normally the percentage does not exceed 5-
10% and the most part derived from reactions of deconjugation as deglycosylation 
[129]. After absorption, they undergo a phase I metabolism, such as oxidation, 
reduction and hydrolysis, and especially a phase II metabolism, as conjugation 
reactions at the level of enterocytes and hepatocytes. Hydrophilic metabolites 
(glucuronide, methylated and sulphates derivatives) are released into the systemic 
circulation and distributed in various tissues or eliminated in the urine [130]. 
High molecular weight polyphenols can be polymeric or oligomeric, such as 
condensed and hydrolysable tannins. These molecules reach the 90-95% of total 
dietary polyphenols intake and are not absorbed in the small intestine, but reach 
the colon partially altered [130]. In the large intestine their concentration can reach 
the millimolar range and the intestinal microbiota is responsible of their 
metabolism. Metabolism usually involves the cleavage of glycosidic bonds, and 
the breaking of the heterocyclic structure. For instance, the catabolism of 
proanthocyanidins (oligomers and polymers of flavan-3-ols) determines the 
production of lactones, aromatic and phenolic acids with different patterns of 
hydroxylation and length of the side chains (phenylvaleric acids, phenylpropionic 
acids, phenylacetic acids, benzoic acid) [131,132]. 
Ellagitannins metabolism is located in intestinal lumen, through hydrolysis 
reactions releasing ellagic acid. In the large intestine, this compound is 
metabolized by the microflora and causes the production of urolithins with a 
decrease number of hydroxyl groups, going from urolithin D → C → A → B 
[133,134]. These phenolic metabolites can be partially absorbed or eliminated in 
the faeces. Once absorbed, they reach the liver through the portal vein, where they 
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are subjected to phase II metabolism (glucuronidation, methylation, sulphation or 
a combination of these processes). These molecules reach the systemic circulation 
and distribution to various organs, and are then eliminated through urine. 
Microbial glucuronidase and sulfatases activity can deconjugate the phase II 
metabolites extruded through the bile during the enterohepatic circulation, 
allowing the re-uptake and an increase in the bioavailability [135]. 
 
 
Figure 15: Metabolic fate of dietary polyphenols and derivatives [130] 
 
Interaction mechanism of polyphenols with bacterial membrane 
The influence of polyphenols on bacterial growth and metabolism depends on 
their structure, dose and type of microorganisms considered [56]. For example, 
Gram-negative bacteria are more resistant than Gram-positive, probably due to 
differences in the cell wall composition [136]. 
The mechanisms of action used by polyphenols on the bacterial flora are various. 
For example, polyphenols can bind the membrane of the bacterial cells, depending 
on the concentration, and alter its functions and inhibit the growth. Catechins act 
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on various bacterial species (E. coli, Bordetella bronchiseptica, Serratia 
marcescens, Klebsiella pneumonias, choleraesis Salmonella, Pseudomonas 
aeruginosa, Staphylococcus aureus and Bacillus subtilis), generating hydrogen 
peroxide [137] and altering microbial permeability [138]. Another proposed 
mechanism, observed in some studies of catechins and theaflavins, highlighted the 
ability of polyphenols to create hydrogen bonds between the hydroxyl groups and 
cell membranes [139,140]. 
After exposure to polyphenols presence, microbial synthesis of defensive proteins 
increases to protect the cell, but at the same time their metabolic activity decreases 
reducing the formation of biosynthetic proteins, amino acids, phospholipids and 
SCFA [130]. 
Polyphenols can also interfere in the release of small signal molecules of bacterial 
cells of E. coli, Pseudomonas putida and Burkholderia cepacia, able to activate 
the exponential growth of microbial population [141]. 
In addition, the B ring of flavonoids can intercalate or form hydrogen bonds with 
the bases of nucleic acids, inhibiting the synthesis of DNA and RNA [142]. Recent 
studies have indeed confirmed that quercetin inhibit bacterial DNA gyrase by 
binding to adenosine triphosphate level of the B subunit [143]. 
Another possible mechanism could be polyphenols ability to form complexes with 
metal ions, which can determine a lack of iron in the intestine and affects bacterial 
populations, mainly aerobes [144]. These bacteria require iron for many functions, 
such as for the activity of ribonucleotide reductase, useful for the synthesis of 
DNA, and the formation of heme groups. 
Many other mechanisms of polyphenols action on specific bacterial intestinal 
functions are still unknown and further research is needed for a better 
understanding. 
 
Modulation of microbiota by polyphenols 
The inter-individual differences in the composition of the microflora bacteria can 
lead to differences in the bioavailability of polyphenols [145] which can be 
converted to bioactive compounds by microbiota, alterating intestinal microbial 
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balance and thus also the host’s health. The administration of specific doses of 
polyphenols may inhibits some bacterial groups and allows others to prosper. For 
example, administering to rats red wine extracts rich in proanthocyanidins for a 
period of 16 weeks, the concentration of Lactobacillus and Bifidobacterium 
decreases in favor of an increased concentration of Clostridium and 
Propionibacterium, resulting a negative effect to health [146]. 
The regular intake of polyphenols from red wine in human determines the growth 
of Bacteroides, resulting in low levels of blood pressure and reduction of 
triglycerides and HDL cholesterol, as well as an increase of Proteobacteria, 
responsible of uric acid degradation [147]. 
Other studies showed that a diet rich in tannins administered to mice leads to an 
increase in the number of Bacteroides, while Clostridium Leptum undergoes a 
strong decrease [144]. 
Phenols from cocoa can promote the growth of Lactobacillus and 
Bifidobacterium, also increasing butyrate production. These changes are 
associated with a reduction of inflammation marker, as triacylglycerol and C-
reactive protein in plasma, with a benefit to human health [148,149]. 
Ellagic acid is metabolized in the gut microbiota to urolithins, but there are inter-
individual variability, both qualitative and quantitative, in its bioconversion. 
According to a study by Tomás-Barberán et al., three phenotypes can be 
identified: most common phenotype (A) produces only urolithin A conjugate, 
phenotype B produces iso-urolithin A and / or urolithin B in addition to the A and 
phenotype 0 does not produce any kind of urolithin [150]. 
Recently bacteria belonging to the genus Gordonibacter have been isolated from 
human feces, and in vitro and in vivo studies have shown their ability to degrade 
ellagic acid [151]. Additional studies demonstrated an increase in the 
concentration of urolithin A, but there was a decrease in concentration of iso-
urolithin A and / or urolithin B, depending on the phenotype examined. Other 
bacteria of the intestinal microbiota are responsible for in vivo production of 
urolithins. To date, more studies are needed for their identification and 
characterization. This approach could lead to the development of probiotics and 
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prebiotics that can increase the concentration of urolithin A metabolite with cardio 
protective, anti-inflammatory and anti-cancer properties [152]. 
Metabolism of trans-resveratrol by the microbiota differs between individuals. So 
far, identified metabolites in vivo and in vitro are the dihydroxy-resveratrol, the 
3,4'-dihydroxy-trans-stilbene and 3,4'-dihydroxy-dibenzyl (lunarin) and their 
quantity and presence vary individually. Two strains, Slackia and Adlercreutzia 
(genera belonging to the phylum Actinobacteria), were identified as main 
responsible in the production of dihydroxy-resveratrol. However, intestinal 
bacteria involved in reductive processes such as the elimination of the double bond 
or dehydroxylation are not yet identified [153]. 
 
Figure 16: Possible metabolism of trans-resveratrol [153] 
Further interaction between trans-resveratrol and microbiota depends on 
stilbene’s ability to inhibit bacterial species including Gracilibacter 
thermotolerans, Parabacteroides distasonis and various species belonging to the 
class of Clostridia (Clostridium aldenense, Clostridium hathewayi, Clostridium 
sp. MLG661), while there is a significant increase of the Clostridium sp. XB90. 
However, the microbial composition is not strongly affected in rats [154]. 
To date in literature, there are a lack about the modulation of the microbiota 
composition by phenolic molecules derived from olive residues, such 
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The aim of the studies included in this PhD thesis, was to improve the knowledge 
about intestinal microbiota after oral administration of polyphenols-enriched 
extracts. According to literature, lack information are available to date on the 
interaction between phenols and intestinal microbiota. In this work, several 
experiments were performed using the gut simulator Mucus-SHIME® or M-
SHIME®. The SHIME® is a validated model of the complete gastro-intestinal 
system, constituted by different vessels simulating stomach and small intestine for 
the first food digestion, and colon to investigate changes in the microbial 
community. The M-SHIME® allows investigating also the adhesion of bacteria at 
mucosal part using mucin compartment in colon vessels. 
Three vegetable extracts were selected for administration tests on M-SHIME®. 
The first extract was the dietary supplement Vineatrol® 30. It contains polyphenols 
derived from grape vine, in particular stilbenoids as resveratrol and its dimers (ε-
viniferin) and trimers (myabenol C). The poor bioavailability of these molecules, 
and especially of resveratrol, represents an issue that should be overcome by using 
high concentrations. However, huge quantities of polyphenols can lead to 
antimicrobial effects, causing an alteration of the intestinal microbiota, which is 
closely related to human health. 
The second part of the study was conducted on an olive “pâté” recovered directly 
during the milling process for extra virgin olive oil production. The pâté is 
characterized by a high content of fiber and typical polyphenols derived from 
olive. The second extract was obtained applying a decoction to pomegranate 
mesocarp. This waste represent up to 50% of fresh fruit weight and it is the main 
by-product from juice production. The decoction allowed recovering a good 
amount of ellagitannins and polysaccharides. The high polyphenols content of 
these by-products led to the recovery of bioactive compounds for the production 
of food supplements or nutraceutical ingredients. 
The in vitro tests with M-SHIME® were conducted selecting two different diets: 
one regular feed and one high protein-low sugar diet. The aim was to collect 
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results about polyphenols-microbiota interaction in different environmental 
conditions. 
The studies were carried out from different point of view, considering the mutual 
influence between polyphenols and microbiota. Different parameters were 
considered: 
 polyphenols metabolites, using HPLC/DAD/MS analysis 
 Short Chain Fatty Acids (SCFAs) and NH4+ levels determination 
 microbiota composition, through PCR-DGGE and Illumina sequencing 
on bacterial DNA 
 
The results were evaluated together to obtain correlations among metabolic fate 
of polyphenols and the effects of phenolic compounds on microbial communities, 
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Resveratrol and its derivatives (glycosides and polymers) are polyphenols 
classified as stilbenes. Different foods and plants contain these molecules, such as 
grapes, red wine, some kind of tea, berries and peanuts [1]. These molecules are 
well-known for several biological activities, mainly antioxidant and anti-
inflammatory effects, cardio protection and cancer prevention [2–4]. Although the 
huge amount of studies, often in vitro and in vivo results are contradictory [5]. To 
date, physiological effects of resveratrol and other stilbenes are still not 
completely clear. One explanation involves the metabolic fate of these molecules 
following oral administration. It is demonstrated that only 5-10% of dietary intake 
of polyphenols is absorbed in the small gut while the residual part reaches the 
large intestine [6]. Colon microbiota is then able to metabolize and transform 
stilbenes through many different reactions, till complete disappearance of the 
original molecules in short times [4,7]. These metabolites could maintain the same 
positive properties of the parent compound or could be even toxic for both bacteria 
and human [8]. The colonic absorption of stilbenes and their metabolites is 
estimated between 35% and 80% and the wide range is due to inter-individual 
microbial diversity and consequent different metabolism [9]. 
At the same time, polyphenols and stilbenes influence on gut microbiota is not 
much studied. It’s well-known that polyphenols can modulate composition and 
functionality of microbial community due to their antimicrobial activity [8]. Many 
different mechanism of action on microbial cells are described for polyphenols. 
Due to their structure and their ability to create H-bonds, these molecules seemed 
to be able to provide a huge stress to microbial cells, for instance binding and 
disturbing cells membrane, influencing thus its permeability [6,10,11]. However, 
there is not much information about the effects of these compounds on non-
pathogenic bacteria and on composition and relative ratios between different 
microbial groups. Therefore, it is important to investigate more about mutual 
effects of polyphenols and microbial community in order to understand deeply the 
mechanism of interaction. 
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According to the different range of absorption, due to inter-individual variability, 
it is also convenient to define the highest concentration of these molecules that 
does not affect the microbial community, but that provide a sufficient amount of 
compounds to exert beneficial effects. 
In this context, the use of dynamic in vitro simulators can help the research in 
areas of the gastrointestinal tract that are not easily accessible. Among the 
available simulators, the SHIME® is a validated model of the complete gastro-
intestinal system, with a series of vessels simulating stomach and small intestine 
for the first food digestion, and the different areas of the colon to investigate 
changes occurring in the microbial community. The Mucus-SHIME® (M-
SHIME®) allows to investigate also the adhesion of bacteria at mucosal part using 
mucin compartment in the colon vessels. The aim of this work was to investigate 
the effects of Vineatrol®, a commercial extract containing resveratrol and 
derivatives, on intestinal microbiota, using a gut simulator (i.e. M-SHIME®). 
Vineatrol® is a powder traded for application in healthy foods and dietary 
supplements. 
A triple M-SHIME® experiment was carried out using two different 
concentrations of Vineatrol®. The extract was administrated directly into colon 
vessel, to maximize the concentration of resveratrol and the stilbenes. The effects 
of the extract on the microbial communities were evaluated in terms of 
metabolism (SCFA and NH4+ concentrations) and taxonomic composition (DGGE 
and Illumina sequencing). HPLC/DAD and HLPC/DAD/MS analyses were 
performed to investigate microbial metabolism on Vineatrol®. 
 
Material and methods 
Vineatrol® 30 extract 
Vineatrol® (Breko GmbH, Bremen, Germany), is an extract obtained from 
water/ethanol extraction of resveratrol monomers and oligomers. Grapevine 
shoots of Vitis vinifera used for extraction were cultivated in the wine-growing 
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region Bordeaux (Fr). Main phenolic compounds (stilbenes) are declared in label 
around 30% of the total weight of the extract [12]. 
 
Batch experiments 
Batch incubations of colonic microbial communities were performed to assess the 
effect of the extract on bacterial metabolic activity and composition. Faecal 
slurries were incubated in the presence of the extract, as described previously [13]. 
Negative controls without Vineatrol® were prepared with 1 mL of faecal slurry 
and 4 mL of feed. Two concentrations (1.5 and 2.5 g of extract/L) were selected 
for the experiments, in accordance with literature [9]. Each experiment was 
performed in duplicate.  
Vineatrol® was weighed directly in sterile Hungate tubes. Then, 1 mL of faecal 
slurry and 4 mL of feed were added and the tubes were capped with butyl-rubber 
stoppers, flushed with N2 and incubated at 37°C for 24h. The 5 mL sample was 
used for extraction of SCFA and HPLC/DAD/MS analysis. 
 
M-SHIME® experiments 
A triple M-SHIME® model, inoculated with faecal samples from a healthy donor, 
was performed. The M-SHIME® contains, in addition to traditional luminal 
microbial community [14], some mucin slots to host surface-attached microbes 
[15]. These microcosms (K1-carrier, AnoxKaldnes AB, Lund, Sweden) are 
submerged in mucin-agar. At the start of each experiment, 500 mL of selected 
feed and 80 mucin-covered microcosms were added to proximal colon (PC) unit, 
while the distal colon (DC) unit was filled with 800 mL and the same amount of 
mucin slots. Subsequently, inoculation of the colon reactors was performed with 
40 mL of a 1:5 dilution of fresh stools of the healthy human donor [16]. After an 
initial incubation of 18 h, 140 mL nutritional medium and 60 mL pancreatic juice 
were supplied to each proximal colon compartment three times per day. The M-
SHIME® was kept at 37 °C and anaerobic condition by flushing for 10 min with 
N2 every day. 
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Three couples of PC and DC vessels ran simultaneously: one couple for control 
and the other two for different treatments with Vineatrol® [Figure 1]. 
 
 
Figure 1 - M-SHIME® design 
After a stabilization period of 2 weeks, daily doses of the extract were 
administrated in the PC vessel for 10 days [Figure 2]. At the end of the treatment, 
a 4-day washout period was then carried out. Two doses were selected for the 
experiment, 1 and 2 g/L, looking for a concentration without negative effects 
according to batch experiments. Three times per week, at the same time of the 
day, 20 mL of liquid sample were collected from each colon vessel. 1 mL was 
centrifuged and the pellet was stored at -20 °C for DNA extraction. Residual liquid 
was stored at -20 °C for metabolic analyses. 
 
 







All samples were reported in plots and, throughout the text, with following 
abbreviations [Table 1]. 
 
PCC dX Proximal Colon Control day X(0,3,5,7,9,11,13) 
DCC dX Distal Colon Control day X(0,3,5,7,9,11,13) 
PC1 dX Proximal Colon dose 1 day X(0,3,5,7,9,11,13) 
DC1 dX Distal Colon dose 1 day X(0,3,5,7,9,11,13) 
PC2 dX Proximal Colon dose 2 day X(0,3,5,7,9,11,13) 
DC2 dX Distal Colon dose 2 day X(0,3,5,7,9,11,13) 
Table 1 – Samples abbreviations. C= Control, 1= dose 1 and 2= dose 2. 
dX = day of sampling 
 
Metabolite measurement 
SCFA analysis were performed according to standard method [17]. A liquid-liquid 
extraction with diethyl ether was applied on frozen samples, after the addiction of 
H2SO4 and internal standard. SCFA quantitative analysis were performed by 
capillary gas chromatography coupled with a flame ionization detector (GC-FID), 
to measure acetic, propionic, butyric, isobutyric, caproic, isocaproic, valeric and 
isovaleric acids. 
NH4+ was analysed by steam distillation according to standard methods (4500-
NH3 B; APHA, 1992). Determination of total ammoniacal nitrogen (TAN) in 
liquid luminal samples was performed through the quantification of NH4+ by the 




Bacterial DNA from luminal samples was extracted as described earlier [18], 
using a Lysis Buffer (TrisEDTA, NaCl, PVP40, SDS, water) and glass beads for 
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FastPrep. DNA extract from mucin was obtained using bead-beating with same 
lysis buffer. Extraction was performed with phenol-chloroform and EtOH/NaOAc 
was used for precipitation [19]. Samples were dissolved in TrisEDTA 1X and 
stored at -20°C. Concentration and quality were verified by Glomax Multi 
Detection system (Promega, USA) and 2% agarose gel electrophoresis. 
 
PCR-denaturing gradient gel electrophoresis (DGGE) 
In order to investigate composition changes in the microbial communities a PCR-
DGGE was assessed as described previously [16]. All samples for PCR were 
prepared starting from 1:10 dilutions. A PCR-DGGE was carried out for total 
bacteria, two nested PCR protocols were performed for Lactobacilli and 
Bifidobacteria. 
External PCR for Lactobacilli was performed using 159F / 667R primers under 
the following conditions: initial denaturation 95 °C for 7 minutes; 35 cycles at 
94°C for 1 minute, 56°C for 1 minute; 72°C for 2 minutes and a final extension at 
72°C for 10 min [20]. 
External PCR for Bifidobacteria was performed using 164F / 662R primers under 
the following conditions: initial denaturation 95 °C for 7 minutes; 35 cycles at 
94°C for 1 minute, 62°C for 1 minute; 72°C for 2 minutes and a final extension at 
72°C for 10 min [21]. 
Internal PCR (Lactobacilli and Bifidobacteria) and amplification for total bacteria 
of 16S rRNA gene were performed with primers 338F-GC and 518R. Cycling 
conditions were: initial denaturation 94 °C for 5 minutes; 30 cycles at 95°C for 1 
minute, 53°C for 1 minute; 72°C for 2 minutes and a final extension at 72°C for 
10 min [22]. 
PCR products were separated on denaturant gradient of polyacrylamide gel 
(DGGE). DGGE (Denaturing Gradient Gel Electrophoresis) was performed [23] 
using the INGENY System (Ingeny International BV, The Netherlands). PCR 
fragments were loaded on an 8% polyacrylamide gel in 1´TAE buffer (20 mM 
Tris, 10 mM acetate, 0.5 mM EDTA pH 7.4). Polyacrylamide gels were prepared 
with 45-60% denaturing gradients for total bacteria and Lactobacilli, and 50-65% 
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for Bifidobacteria. Electrophoresis was run for 16 hours at 60°C and 120 V. 
Staining and analysis of the gels was performed as described previously [24]. 
The normalization and analysis of DGGE gel patterns was done with the 
BioNumerics software 5.10 (Applied Maths, Sint-Martens-Latem, Belgium). 
During the processing, lanes were defined, background was subtracted, 
differences in the intensity of the lanes were compensated during normalization 
and band classes were detected. A matrix of similarities for the densiometric 
curves of the band patterns was calculated based on the Pearson product–moment 
correlation coefficient. A composite dataset was created by merging the 
information from the all the band patterns in order to obtain a combined 
dendrogram – using UPGMA linkage – containing the information from the gels 
on total bacteria, bifidobacteria and lactobacilli.  
 
Illumina Sequencing 
Samples collected from all vessels (PCC, DCC, PC1, DC1, PC2, DC2) at different 
times (d0, start up; d9, end of the treatment; d13 after washout) were selected for 
Illumina sequencing. Genomic DNA was extracted as previously described [18] 
with the following modifications. Samples were suspended in 1 mL Tris/HCl (100 
mM pH 8.0), supplemented with 100 mM EDTA, 100 mM NaCl, 1% (wt/vol) 
polyvinylpyrrolidone and 2% (wt/vol) sodium dodecyl sulfate, transfered to a 2 
ml Lysing Matrix E tube (Qbiogene, Alexis Biochemicals, Carlsbad, CA), 
subjected to mechanical lysis in a Fast Prep-24 instrument (40 s, 6.0 m s-1) and 
purified as described. The V1-2 region of the 16S rRNA gene was amplified as 
previously described [25]. In a first 20 cycles PCR reaction the 16S rRNA gene 
was enriched using the well-documented 27F and 338R primers [26,27] as 
previously specified [28]. Libraries were sequenced in a MiSeq platform 
(Illumina). 
Pair-end Raw sequences were assembled and aligned using mothur [29] and 
subsequently filtered as previously described [25]. Briefly, reads were clustered 
allowing for two mismatches using mothur. The data-set was then filtered to 
consider only those phylotypes that were present in at least one sample at a relative 
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abundance > 0.1% or were present in all samples at a relative abundance > 
0.001%. A total of 1,591,358 reads were obtained, and grouped into 1747 
phylotypes. Rarefaction curves and statistics were generated using the package 
vegan from the R program. All phylotypes were assigned a taxonomic affiliation 
based on the naïve Bayesian classification (RDP classifier) [30] with a 80% of 
confidence. Obtained tables, ranking the identified phylotypes and their 
abundance, have been used to describe the relative their relative abundance - at 
order and phylum level - in each sample and to produce cluster dendrograms and 
PCA (principal component analysis) graphs. 
 
HPLC/DAD/MS analysis of colonic metabolites 
For HPLC/DAD/MS analysis two samples from PC control vessel were added 
with Vineatrol® at the same concentrations used for the experiment, to evaluate 
time zero profiles (PCCVINEA1 and PCCVINEA2). These samples were then 
compared with PC1, DC1, PC2 and DC2 samples collected during the experiment 
(d3, d5, d7, d9, d13) and with vessels content before the administration (PC1d0, 
DC1d0, PC2d0 and DC2d0) to identify any possible interferences due to feed. 
Samples for HPLC/DAD analysis were pre-treated in order to obtain a clean 
solution as follows: 2 mL of surnatant from liquid luminal material of defrost 
suspension were added with 0.5 mL of MeOH/Acetonitrile/Acetone (1/1/1) and 
mixed with Vortex, then kept at room temperature for 25 min. The suspension was 
then centrifuged at 4 °C, 5000 rpm, 10 min. Supernatant was recovered and used 
for analysis. 
Qualitative analysis were performed using a HP 1100 liquid chromatography 
coupled with HP 6200 series MS/TOF (Agilent Technologies, USA). A 150mm×2 
mm i.d., 4μm, RP-18, Sinergi Fusion column (Phenomenex, USA) was used. 
Eluents selected were (A) H2O pH 3.2 with formic acid and (B) CH3CN. The used 
multi-step linear solvent gradient was: 0-2 min 20-20% B; 2–25 min, 20–50% B; 
25–27 min 50–100% B; 27-33 min 100-100%; 33-35 min 100-20%, equilibration 
time 10 min; flow rate 0.2 mL/min. The UV-Vis spectra were recorded in the 
range 200–500 nm and the chromatograms were acquired at 240 nm, 254 nm, 280 
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nm, 307 nm, 320 nm. MS spectra were acquired using Dual-ESI source in negative 
polarity with 100 V fragmentor, 3800 V capillary voltage, 350°C of gas 
temperature. 
Quantitative analysis were carried out using a HP 1200 liquid chromatography 
equipped with a DAD detector (Agilent Technologies, USA), using the same 
column and method applied for qualitative analysis. Stilbenes content was 
determined by HPLC/DAD. A MilliQ water solution of trans-Resveratrol (Sigma 
Aldrich) 0.0214 mg/mL was used to create a calibration curve at 307 nm in the 




SCFA levels, in controls and samples treated with Vineatrol® after 24h, were 
investigated by GC-FID. Two replicates, A and B, were performed for each 
concentration (1.5 g/L and 2.5 g/L). The same SCFA levels were observed in 
samples treated with Vineatrol®, at both concentrations, as compared to control 
[Figure 3]. No significant differences were observed after the treatment with 
selected dosages of Vineatrol® and the microbial activity was not affected by the 
extract at these concentrations after 24h. 
 




In order to investigate the Vineatrol® metabolism, control samples added with 
fresh Vineatrol® and samples treated (both concentrations and both replicates) 
were analysed by HPLC/DAD/MS. Figure 4 shows the profiles from control and 
replicates A and B of samples treated with the highest concentration (2.5 g/L). 
The concentrations of the main components suffered a strong decrease and 
viniferin’s signal almost disappeared. The same evolution was detected also for 
lower concentration.  
According to these results, the doses for the first SHIME® experiment were then 
assessed at 2 g/L and 1 g/L. 
 
 
Figure 4 – HPLC/DAD profiles at 307 nm of samples from 24h batch experiments. Control 
and replicates (A/B) at higher concentration (2.5 g/L) are reported. Main compounds were 
identified as trans-resveratrol (1) and ε-viniferin (2). 
 
Vineatrol® effects on microbial metabolism in M-SHIME® 
experiment: SCFA and ammonium  
The effects of Vineatrol® administration in the M-SHIME® experiment were first 




SCFA levels significantly decreased after treatment with both selected doses 
[Figure 5]. PC and DC metabolism showed similar trends and administration of 
the extracts provided the same effects, even with different doses. Subsequently, 
during the washout period, SCFA levels showed again an increasing trend. The 








Figure 6 - NH4+ level evolution at different time sampling  
 
Vineatrol® effects on microbial community composition in M-
SHIME® experiment 
PCR-DGGE measurement 
PCR-DGGE for total bacteria, Bifidobacteria and Lactobacilli were performed on 
samples collected immediately before starting the treatment (Day 0), halfway and 
end of treatment (Day 5-9) and after washout (Day 13). DGGE images were 
processed through Bionumerics software to identify patterns and define the 
clusterization through composite data set. 
Separation among control and treated samples was well defined [Figure  7]. PC1 
treated samples (higher concentration) resulted different from control and starting 
point. In particular, correlation values of PC1 d5/d9/d13 compared with PC1 d0 
and PCC were low, down to 40%, meaning that the microbial communities 
changed after administration of Vineatrol®. Pattern from DC1 vessels did not 
show the same evolution and showed 80% correlation, indicating smaller 
variations among d0 and samples collected during and after the treatment. PC 
samples treated with the lower concentration demonstrated a weak change 
compared to the starting point. However, correlation values are around 70% 
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among d0 and following times, meaning that the administration of the extract 
poorly affected the composition of the microbial communities. The evolution of 
DC2 at time zero and during/after the treatment did not show significant 
variations, since the samples clustered together with high correlation (> 80%). 
In summary, the higher concentration had a stronger effect on proximal vessel. 
For the lower dosage, the effect on PC was consistent with the higher one, but the 
variation seemed less strong. Effects on DC1 and DC2 were not much evident 
during the treatment, probably due to lower concentrations reaching these vessels. 
The effects are more marked in PC since the extract administration was provided 
directly in that vessel and more time was required to reach an effective 
concentration in DC vessel. It is clear that Vineatrol® had an effect on the 
microbial composition at both tested concentrations (2 and 1 g/L). 
 
Figure 7 – Composite data set of DGGE patterns 
 
Illumina sequencing 
As shown in Figure 8 and 9, microbial communities from control and treated 
vessels were compared at the phylum and order level. 
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Despite the intrinsic variability, the microbial communities treated with higher 
dosage showed a strong change during the treatment. In PC1 d9 and PC1 d13 
collected from lumen, it is possible to observe that the phylum Proteobacteria was 
enriched and the phylum Bacteroidetes decreased during the treatment. In 
particular, a significant enrichment of Enterobacteriales was observed, while the 
abundance of the order Bacteroidales decreased. This trend in PC1 vessel was 
more intense in mucin than in lumen samples. The interruption of treatment did 
not provide a fast return to original conditions, since the microbial community 
from lumen after the washout (PC1 d13) was similar to the microbial communities 
enriched during the treatment. In mucus samples, after the washout the 
composition returned close to starting point condition. Comparable behaviour was 
observed also in samples DC1 d9 and DC1 d13. The same taxonomic groups 
dominated the microbial communities after the treatment. The order Synergistales 
(phylum Synergistetes), which was abundant in the inoculum, was outcompeted 
during the treatment. Also the abundance of the order Erysipelotrichales 
decreased during the treatment.  In samples treated with lower concentration, a 
similar evolution was shown. PC2 d9 and PC2 d13, from both lumen and mucus, 
presented the enrichment of the order Enterobacteriales and correspondent 
decrease of the order Bacteroidales, but in lesser extent than PC1 samples. In this 
case, the 4 days wash out seemed to be enough to revert the effects of the 
treatment. In DC2 samples, no significant changes were detected. As seen for 
DC1, some less represented order, Synergistales and Erysipelotrichales, was also 
outcompeted. 
Cluster dendrogram of lumen samples, shown in Figure 10, confirmed the 
significant changes in PC1 and PC2 after treatment. Samples from proximal vessel 
from time d9 and d13 clustered together. DC1 d9 and d13 appeared separated from 
other DC, indicating the presence of a different microbial community. The 
samples collected from DC2 and the samples collected from the control grouped 
in the same cluster showing a weak effect of Vineatrol® on the composition of the 
microbial communities. Considering the samples collected from mucus, PC1 and 
PC2 grouped together, with a higher correlation with control than lumen, 
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suggesting a lower effect. Effects on DC1 and DC2 did not result remarkable, in 
particular DC1 d9/d13 and DC2 d9 demonstrated weak differences if compared 
to control, but not relevant. 
 











Figure 10 – Cluster dendrograms of lumen and mucus samples. 
 
PCA for lumen and mucus confirmed the cluster analysis results [Figure 11]. In 
lumen plot, PC and DC from control and starting points were separated in two 
well-defined groups. PC treated samples showed a significant clusterization, since 
PC1 d9/d13 and PC2 d9 overlapped in the same area. As observed in the 
corresponding dendrogram, DC1 d9/d13 were isolated from other DC samples 
showing remarkable differences. PCA for mucus samples was consistent with 
cluster analysis results as well. The group including PC1d9/d13 and PC2 d9, 
formed a different cluster compared to PC control and inoculum (d0) indicating 
that these communities resulted the more affected by the treatment. DC samples 
did not show patterns and grouped together. 
Calculation of the Shannon and richness indexes did not show significant 






Figure 11 – PCA plots for LUMEN and MUCUS samples 
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Stilbenes metabolic fate in M-SHIME® experiment 
The metabolic fate of resveratrol and other stilbenes was investigated by 
HPLC/DAD and HPLC/DAD/MS analysis. Samples collected from PC and DC 
at different time, a blank and a control from PC were treated in order to purify the 
solution for the analysis. Soluble proteins were precipitated and the clean 
supernatant was recovered after centrifugation for HPLC injections. 
A HPLC/DAD/MS analysis was performed to evaluate differences in all samples 
profiles. According to Figure 12, no changes in chromatographic profiles at 307 
nm of different sampling time were observed. Chromatograms were identical in 
control and treated samples and compounds identity was confirmed by ESI-TOF 
analysis. As shown in the chromatograms, two main signals were recorded; they 
were identified as trans-resveratrol (rt=13 min; 227.068 m/z ) and trans-ε-viniferin 
(rt=19 min; 453.13 m/z), according to their UV and MS spectra. Other minor 
compounds were also identified as Myabenol (rt= 20.5; 679.188 m/z) and 
Resveratrol tetramer (tr=21.5 min; 905.244 m/z) [Figure 13]. The same results 




Figure 12 – HPLC/DAD profiles at 307 nm of samples treated with higher concentration of 
Vineatrol®, from PC and DC vessels. 
 
Figure 13 – MS spectra of main stilbenoids in Vineatrol®. 
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PCCVINEA1, PCCVINEA2, and all collected samples from PC1, DC1, PC2 and 
DC2 vessels were then analysed to quantify the concentration of main compounds, 
using the same elution method and the same column. Pure t-resveratrol solution 
was used to create a calibration curve and to express data. ε-viniferin and minor 
derivatives were quantified as resveratrol, applying a specific correction factor 
[31]. Concentrations of samples collected at different times are reported inFigure 
14. The trends of all compounds were similar and consistent. In the PC samples, 
concentrations increased quickly for both doses and reach a plateau, then 
decreased after 4 days washout. Samples from DC showed the same trend, with a 
slower increase, since the extract was added in the PC and just a part of this was 
transferred in DC vessel during each cycle. These consistent results confirmed 
that the extract composition did not change significantly and no relevant 
metabolism was detected. 
 
Figure 14 – Main stilbenes concentration during experiment, in PC and DC vessels 





It is reported that t-resveratrol and its derivatives suffer strong metabolism after a 
single oral administration, and their bioavailability is reduced, also due to 
intestinal microbial functionality. To go beyond that issue, a daily intake of 
Vineatrol® was administered at colon level. In this work, many aspects were 
evaluated to investigate the mutual effects of phenols contained in dietary 
supplement and gut microbial community. T-resveratrol and derivatives usually 
suffer several transformation, and their bioavailability is very low, as almost all 
phenolic compounds [4,32,33]. At the same time, t-resveratrol owns well-known 
antimicrobial activity [34]. The aim of this work was to highlight the 
administration effects of a stilbene-enriched extract, Vineatrol®, on intestinal 
microbial community using a gut simulator. 
The doses of Vineatrol®, for the treatment in in vitro simulator M-SHIME®, were 
selected through batch experiments with single administration of different 
concentrations. The evaluation of microbial functionality and stilbenes metabolic 
fate were consistent with literature, where the metabolization of t-resveratrol and 
other stilbenes after a single administration was clearly observed in in vivo test 
[9]. SCFA levels were stable in control and treated samples, while the 
concentration of main stilbenes decreased (indicating that t-resveratrol and its 
derivatives suffered a metabolization by microbiota). Two dosages were then 
assessed for test with M-SHIME®. 
The microbial communities were studied in terms of composition and 
functionality. SCFA and NH4+ are the products from sugar fermentation and 
proteolysis. Their levels are considered a clue of wellness of microbial population. 
In PC and DC control, their concentrations showed a regular trend all over the 
period. On the other hand, SCFA and NH4+ levels resulted strongly reduced by the 
administration of Vineatrol®: PC1, DC1, PC2 and DC2 trends showed a decrease 
during the treatment, with a weak return to starting value after the washout. In 
particular, the higher dose led to a more intense effect in both PC and DC samples. 
The overall functionality resulted affected. 
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The second step of the study was to evaluate changes in microbial composition. 
The preliminary study through DGGE on lumen samples highlighted significant 
differences among control and treated communities. These modifications were 
then deeply investigated using an Illumina sequencing on DNA extracted from 
lumen and mucus samples. The results obtained from sequencing were consistent 
with an alteration of the microbial functionality and pointed out that communities 
treated with higher dosage showed a strong change in overall composition, in both 
lumen and mucus materials. Variation after treatment with Vineatrol® was more 
evident for PC1 than for DC1 community. In PC2 and DC2, challenged with lower 
concentration of extract, the evolution was similar, but in less extent. Most 
important information is about the enrichment of Enterobacteriales and the 
decrease of Bacteroidales order. The Enterobacteriaceae are a large family of 
Gram-negative bacteria that includes, along with many harmless symbionts, many 
of the more familiar pathogens, such as Salmonella, Escherichia coli, Yersinia 
pestis, Klebsiella and Shigella. Bacteroidetes are involved in relevant functions 
and healthy metabolism of gut microbiota. 
The results on microbial communities during the treatment were consistent with 
information obtained from SCFA and NH4+ levels. In terms of communities, a 4-
day washout was not sufficient for a return to starting situation, in particular in 
PC1 (with higher dosage). However, SCFA and NH4+ levels showed a weak 
increased after the treatment. Microbial functionality, in terms of SCFA and NH4+, 
seemed to recover quickly, while for the establishment of the communities’ 
composition more time could be required. 
The evaluation of stilbenes metabolic fate was the last part of the work. Despite 
positive results from preliminary batch experiments that confirmed the 
metabolization of t-resveratrol and derivatives after a single administration, a 
continuous treatment with repeated intake for several days, led to interruption of 
normal metabolism. Main compounds were not transformed and their 
concentration increased during the experiment, indicating that the polyphenols 





Results obtained on stilbenes metabolic fate and microbial functionality and 
composition pointed out a strong negative affection, mainly induced by a 
continuous administration of this extracts. Results suggest that a similar approach 
did not seem a proper solution to increase the bioavailability of these compounds 
in vivo, since they modify significantly microbiota equilibrium, with potential 
negative consequences on human health. Further studies with lower 
concentrations need to be developed and, at the same time, alternative methods of 
administration should be taken into account to provide the maximum beneficial 
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In last years, sugar free diets with high protein content became a trendy approach 
for weight-loss all over the world [1]. These type of diet provides some positive 
effects, such as a fast decrease of fat mass and enhancement of insulin sensitivity 
[2]. On the other hand, it is important to remind that a severe decrease of 
carbohydrates affects the wellness of colonic region. A strong decrease of total 
short-chain fatty acid (SCFA) concentrations is reported as consequence of low 
carbohydrates diet [3,4]. Since SCFA demonstrated beneficial effects, 
concentration decreasing provides a deterioration of wellness. In addition, high 
protein intake could lead to many potential dangerous situations. Since more 
proteins arrive at colon region, their transformation provides increased amount of 
fermentation products, like nitrogenous metabolites [5,6]. Many studies 
demonstrated that these molecules are involved in increasing colon cancer risk 
and inflammatory disease [7–9]. 
The effects of polyphenols dietary intake is also widely investigated. Several 
studies about beneficial effects of these molecules in in vitro and in vivo models 
was published in last the years [10–13]. Many properties are attributed to phenolic 
compounds, such as anti-oxidant [10,14,15], anti-inflammatory [16–19], 
cardiovascular protection [20–23] and chemopreventive activities [24–28], but in 
vivo mechanisms are not yet clear. According to these results, polyphenols intake 
could then contrast adverse consequences reported for high protein diets. 
Moreover, dietary fiber and non-digestible carbohydrates are fermented by 
microbial community, so they can contrast the SCFA decrease and provide 
positive effects [29–31] and also improve the release of phenolic compound from 
vegetable materials [32]. In 2011, a study reported that 50% of dietary 
polyphenols cross the small intestine linked to fiber [33]. One other work showed 
how the combination of fiber and phenols could improve functionality of different 
foods [34]. 
One example of vegetable matters including polyphenols are food wastes. Food 
by-products derive mostly from food processing and farming, where huge 
amounts of discards are produced [35]. These wastes are used often for biofuel or 
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bioenergy production processes [36]. However, many discards from plants are 
also considered as sources of fiber and bioactive polyphenols. There are many 
example of wasted plants material studied as candidates for the recovery of 
bioactive compounds, such as cereals, roots, oil crops and fruit/vegetables. [37]. 
One of the most interesting food process is the olive oil production and many 
approaches were studied in order to recover both polyphenols and fiber from 
milling by-products (wastewaters and pomace) [38–44]. Several works are 
reported also about pomegranate discards, in particular seeds and peel [45], as 
source of phenolic compounds and polysaccharides [46,47]. Different approaches 
were investigated to obtain the higher yields, with various results confirming high 
content of active compounds [45,48]. 
It is important to know that the body recognizes polyphenols as xenobiotics and 
their bioavailability is lower than common macro and micronutrients, which suffer 
different metabolism [11]. Moreover, the bioavailability of phenolic compounds 
depends also on inter-individual differences in the composition of the microbial 
community, which can be converted to bioactive compounds by microbiota, 
modifying intestinal microbial balance and thus also the host’s health [49]. 
The aim of this work was to investigate about potential benefits of two food by-
products, containing both fiber and bioactive polyphenols, when administered in 
addition to diets with high protein and low carbohydrates content. 
The selected by-products were an olive “pâté” (OP), derived from extra virgin 
olive oil production and made up of wet pulp, and a decoction of pomegranate 
mesocarp (PM), which represent the most abundant waste from pomegranate juice 
production. A Triple M-SHIME® experiment was performed to investigate the 
effects of oral administration considering polyphenols metabolic fate 




Material and methods 
Food by-products 
Two extracts were used in the experiment with simulator. Pomegranate 
(Wonderful cv) from Tuscan farming was selected. Mesocarp was separated from 
the other parts, then washed with water. Once dried, a 1h decoction was applied. 
Suspension was freeze-dried, grounded and used as powder (PM). 
Polysaccharides were precipitated by the addition of two volumes of EtOH to 
original decoction and keeping the solution at 0°C for 3h. Solid residue were 
weight and the total amount was 12%, referring to the dried extract [50]. 
The second sample derived from a water suspension of residual material from 
olive oil production, named olive “pâté” (OP) that includes wet pulp and husk. 
The liquid suspension was freeze-dried. Powder was defatted adding hexane and 
stirring for 1 h. The solvent was then recovered and powder was dried. The 
producer declared in label a total fiber content of 24%, according to standard 
method for determination of fiber in vegetable materials. 
 
HPLC/DAD/MS analysis 
Quantitative analysis were performed on PM and OP, preparing samples as 
described below. 
PM sample was prepared solving the extract 10 mg/mL in H2O. Two consecutives 
extraction with EtOH/H2O 8:2 v/v were applied to OP. The extracts were gathered 
together and dried under vacuum. Final powder was solved in EtOH/H2O 8:2 v/v. 
For PM characterization, stock solution of α+β punicalagins, 1 mg/mL, was 
prepared in DMSO, then diluted with H2O before the HPLC analysis; solution of 
ellagic acid 0.78 mg/mL was prepared in MeOH. The calibration curve of α+β 
punicalagins (380 nm) was in a linearity range between 0.5-8 μg with a R² = 
0,9982; the calibration curve of ellagic acid (370nm) was in the linearity range of 
0,031–1,25 μg with R² = 0,9995. PM samples were analysed using a 150mm×2 
mm i.d., 4μm, RP-18, Sinergi Fusion column (Phenomenex, USA). Eluents 
selected were (A) formic acid/H2O and (B) CH3CN. The multi-step linear solvent 
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gradient used was: 0-4 min 5-25% B; 4–8 min, 25–25% B; 8–14 min 25–35% B; 
14-16 min 35-90%; 16-18 min 90-5%, equilibration time 10 min; flow rate 0.4 
mL/min. The UV-Vis spectra were recorded in the range 200–500 nm and the 
chromatograms were acquired at 240 nm, 280 nm, 330 nm, 370 nm, 380 nm. MS 
spectra were acquired using Dual-ESI source in negative polarity with 100 
fragmentor, 4000 V Capillary Voltage, 350°C of Gas Temperature. 
For OP hydroxytyrosol and tyrosol were quantified using a calibration curve of 
tyrosol standard with R² = 0.999 and recording the areas at 280 nm. Oleuropein 
and its derivatives were quantified applying a four-point calibration curve 
obtained with standard oleuropein with R² = 0.999 and recording areas at 280 nm. 
Verbascoside and phenylpropanoids derivatives were quantified using caffeic acid 
calibration curve obtained with R² = 0.999 and recording areas at 330 nm. The 
amount of verbascoside in particular, was measured using a correction factor of 
weight equal to 3.47. A 150mm×3 mm i.d., 2.7 μm, RP-18, Poroshell column 
(Agilent Technologies, USA) was used. Same eluents were selected. The multi-
step linear solvent gradient used was: 0-40 min 5-40% B; 40–45 min, 40–40% B; 
45–50 min 40–100% B; 50-53 min 100-100%; 53-55 min 100-5%, equilibration 
time 10 min; flow rate 0.4 mL/min. The UV-Vis spectra were recorded in the 
range 200–600 nm and the chromatograms were acquired at 240 nm, 280 nm, 330 
nm, 350 nm, 540 nm. MS spectra were acquired using Dual-ESI source in negative 




One Triple M-SHIME® model was performed inoculating with faecal samples 
from a healthy donor. The M-SHIME® contained, in addition to traditional 
luminal microbial community [51], a special feed without sugars including: yeast 
extract 3.0 g/L, peptone 1.0 g/L, and pig gastric mucin 4.0 g/L. At the start of each 
experiment, 500 mL of selected feed was added to Proximal Colon (PC) unit, 
while the Distal Colon (DC) unit was filled with 800 mL. Following inoculation 
was performed with 40 mL of a 1:5 dilution of fresh stools of a healthy human 
 
87 
volunteer [52]. After an initial incubation of 18h for pH stabilisation, 140 mL 
nutritional medium and 60 mL pancreatic juice were supplied to each proximal 
colon compartment three times per day. The M-SHIME® was kept at 37 °C and 
anaerobic condition by flushing for 10 min with N2 every day. 
After a stabilisation period of 2 weeks, daily doses of extracts were administrated 
directly to PC vessel, for 10 days. The experiment was performed administering 
4 g/L of OP and 2 g/L of PM [Figure 1]. 
Three times per week, at the same time of the day, 20 mL of liquid sample were 
collected from each colon vessel. Luminal liquid was stored at -20°C for 
metabolic analyses [Figure 2]. 
 
 









Short Chain Fatty Acids analysis 
For SCFA analysis, a liquid-liquid extraction with diethyl ether was applied on 
frozen samples, after the addiction of H2SO4 and internal standard. SCFA 
quantitative analysis was performed using capillary gas chromatography coupled 
with a flame ionization detector (GC-FID), to measure acetic, propionic, butyric, 
isobutyric, caproic, isocaproic, valeric and isovaleric acids. 
 
Results 
Composition of PM and OP 
The two materials were analyzed with optimized methods and quantitative content 
was assessed using pure standards. 
In PM, ellagitannins content was evaluated in terms of α + β punicalagins, as most 
abundant compounds, and ellagic acid and its glycosides, as minor components 
[Figure 3 and 4]. A overall amount of 120.21 mg/g of dried sample, in terms of 
total tannins, was obtained. As expected, the α + β punicalagins resulted the main 
compounds reaching 70.7 mg/g in mesocarp decoction [Table 1]. Ellagic acid was 
also well represented in the extracts, with a concentration of 3.67 mg/g. 
 
Figure 3 - Chromatograms at 370 nm of PM. 






Figure 4 – Structure of main phenolic compounds in PM. 
Products Compounds Concentration (mg/g) 
PM 
α+β punicalagins 70.7 
Ellagic acid and 
derivatives 
10.70 
Total tannins 120.2 
Table 1 - Tannins content of PM in terms of mg/ g of dried material 
 
Considering the different classes of phenolic compounds included in Olea 
Europea, polyphenols content of OP was calculated using three different external 
standards: tyrosol (form small phenols), oleuropein (for secoiridois class) and 
caffeic acid (for verbascoside and derivatives) [Figure 5 and 6 – Table 2]The most 
abundant class correspond to oleuropein derivatives, with a total concentration of 
77.77 mg/g. OP resulted rich in term of hydroxytyrosol, while tyrosol 
concentration was lower. Verbascoside was also significantly present in the 
extract. The overall amount of polyphenols was quite high, reaching a total content 






Figure 5 - Main polyphenols identified in OP 
 
Figure 6 - HPLC profiles at 280 (red) e 330 (green) nm from OP sample. 
Hydroxytyrosol (1), tyrosol (2), caffeic acid (3), oleuropein-aglycone mono-aldehyde (4), 









Oleuropein derivatives 77.77 
Luteolin 0.42 
Total polyphenols 97.55 
Table 2 – Polyphenols content of OP in terms of mg/ g of dried material 
 
Phenolic profiles and content of these two samples, shown in Tab 1 and 2 and 
Figure 3 and 6, are characterize by the presence of several compounds. Part of 
them will be metabolized and transformed in smaller molecules. 
 
Polyphenols effects on microbial metabolism : SCFA 
SCFAs level was calculated in samples from all vessels at many times (day 0, 2, 
4, 7, 9) through GC-FID. Acetate, butyrate, propionate and total SCFA 
concentrations are reported as most significant [Figure 7]. 
Samples from control vessels, both PC and DC, showed a regular trend during all 
experiment period. As expected, DC levels were higher than PC’s, and the system 
resulted stable over time. 
OP administrated samples presented a different trend compared with control. In 
both PC and DC, an increase of SCFAs level was recorded during the treatment 
period. Concentrations rose about 50%, meaning that fiber, included in OP, were 
used as carbon source by bacterial community. 
Treatment with PM led to similar results. Starting level was lower than other 
samples, but SCFAs showed the same evolution, increasing during all period. 
Even in this case levels got higher in PC and DC along the experiment, probably 




Moreover, the increase provided by OP resulted higher than PM. This result is 
consistent with the overall content of the two samples. OP includes 24% (w/w) of 




Figure 7 – SCFA levels during the M-SHIME® experiment. 
 
Discussion 
The two by-products selected for this study were analysed in order to define 
mainly the polyphenols content. PM showed a high amount of total ellagitannins, 
in particular punicalagins and ellagic acid derivatives. The decoction applied as 
extraction method is then effective to recover main compounds, including 
polyphenols and polysaccharides. This method provides a soluble extract ready 
for the oral administration. 
The profile of OP showed a significant content of phenolic molecules. The 
dominant compound was hydroxytyrosol, but also other molecules, like 




It can be assessed the two selected by-products resulted as a good source of 
polyphenols. 
The evaluation of microbial functionality showed low concentrations in control 
samples, but a significant improvement in SCFA levels was provided by the 
administration for 10 days of these extracts. PM and OP contains molecules that 
are used as C-source by intestinal bacteria, probably fiber and polysaccharide 
included in original raw materials. The same evolution was observed in PC and 
DC vessels administered with the two by-products. 
This preliminary study showed potential benefits of the use of food by-products 
in addition to a high protein/no sugars diet. The content of polyphenols found in 
OP and PM, together with dietary fiber, was very interesting. In addition, the 
increase of SCFA, obtained with the administration of OP and PM, could contrast 
the negative effects of extreme diets, improving microorganism and gut wellness. 
Further investigation will be carried out on metabolic fate of polyphenols and 
effects on microbiota composition, in order to better understand the interaction 
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In 2011 FAO reported that “one-third of the edible parts of food produced for 
human consumption, gets lost or wasted globally, which is about 1.3 billion ton 
per year” [1]. Big discards are also due to an improper treatment of sub-products, 
in particular in agricultural sector and food processing industry. Post-harvesting 
and processing are responsible of more than 40% of losses, mainly in industrial 
countries [2]. In last years, the interest toward food waste valorisation and reuse 
increased much. Some by-products, recovered from different vegetable food, have 
been widely investigated mainly for the development of biofuel or bioenergy 
production [3]. Most wastes from plants resulted to be good candidate also for 
recovery of nutraceutical ingredients, suitable to be included in dietary 
supplements or food formulations. Cereals, roots, oil crops and fruit/vegetables 
by-products are all potential sources of bioactive and functional compounds 
[4].The goal is to define new sustainable processes and techniques to recover and 
transform wastes in suitable extracts enriched in bioactive compounds. 
One of the most investigated food process is the olive oil production. Residues of 
milling process are well-know to own negative properties, such as phytotoxicity, 
pollution of natural waters, affection of aquatic life, due to lipid and phenolic 
content [5]. Different strategies have been proposed and evaluated to manage 
wastewaters and pomace and reduce negative effects, including physical, 
physicochemical and biological treatments [6–12]. However, it was estimated that 
only 2-4% of total phenolic compounds included in olives could be recovered in 
virgin oil during the milling process, while the largest part is thrown away with 
wastes [13]. Different methods to recover these molecules have been studied and 
many processes (industrial or laboratory scale) have been developed [14–17]. 
At the same time, also pomegranate wastes from juice production (seeds and peel) 
were studied as a source of polyphenols, in particular phenolic acids, flavonoids, 
tannins [18,19]. The peel and mesocarp from pomegranate, discarded during juice 
production, could be up to 50% weight of the whole fresh fruit [20–22]. Even in 
this case, different extractions were evaluated in order to obtain maximum yield 
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of main interesting molecules. Despite the variability in the results, all studies 
agree with the high content of active compounds in these by-products [23,24]. 
According to the huge interest on these matrices, we selected two by-products: an 
olive “pâté” (OP), derived from extra virgin olive oil production and made up of 
wet pulp, and a decoction of pomegranate mesocarp (PM), from a widespread 
variety, the Wonderful cultivar. These samples were selected due to previous 
analytical screening. 
It is crucial to remind that, once introduced in the organism through oral 
administration, the body recognizes polyphenols as xenobiotics and their 
bioavailability is lower than that of macro and micronutrients. Low molecular 
weight polyphenols, such as monomeric or dimeric structures, are absorbed in the 
small intestine, but normally the percentage does not exceed 5-10% and the most 
part derives from deconjugation and deglycosylation reactions [25]. High 
molecular weight polyphenols represent 90-95% of total dietary polyphenols 
intake and are not absorbed in the small intestine, but reach the colon partially 
altered [26]. 
The metabolic fate of main polyphenols from olive oil is still not clear and few 
works are reported in literature on colonic transformation of main molecules [27–
29]. It is demonstrated that microorganisms usually degrade main molecules, for 
instance hydroxytyrosol and oleuropein aglycone, but there are not data on the 
effect of the total human microbiota metabolism.  
Regarding pomegranate, ellagitannins metabolism is located in the intestinal 
lumen, through hydrolysis reactions releasing ellagic acid. In the large intestine, 
this compound is metabolized by bacteria and is transformed in urolithins with a 
decrease number of hydroxyl groups, going from urolithin D → C → A → B 
[30,31]. 
Moreover, polyphenols can influence bacterial growth and metabolism depending 
on their structure, dose and type of microorganisms considered [32]. After 
exposure to polyphenols presence, microbial synthesis of defensive protein 
increase to protect the cell, but at the same time their metabolic activity decrease 
reducing the formation of biosynthetic proteins, amino acids, phospholipids and 
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Short Chain Fatty Acids (SCFA) [26]. In the end, the inter-individual differences 
in the composition of the microflora bacteria can lead to differences in the 
bioavailability of polyphenols [33] which can be converted to bioactive 
compounds by microbiota, modifying intestinal microbial balance and thus also 
the host’s health. 
This work focused on the effects of two by-products (OP and PM) on intestinal 
microbiota, using a gut simulator (Mucus-SHIME or M-SHIME®). A duplicate of 
a Triple M-SHIME® experiment was performed to investigate the effects of oral 
administration for several days. These effects were evaluated studying the 
polyphenols metabolic fate (HPLC/DAD/MS analysis), the microbial 
functionality (SCFAs and NH4+ levels) and the microbiota composition (PCR-
DGGE on bacterial DNA). 
The objective was to carry out a study from different point of view, considering 
the mutual influence between polyphenols and microbiota. 
 
Material and methods 
Food by-products 
Two extracts were used in the study. Pomegranate (Wonderful cv) from Tuscan 
farming was selected; fruits were harvested in Grosseto (Tuscany). Mesocarp was 
manually separated from the other parts, then a 1h decoption was applied. 
Suspension was freeze-dried, grounded and used as powder (PM). 
The second derived from a water suspension of residual material from olive oil 
production, named olive “pâté” (OP), that includes wet pulp and husk. The liquid 
suspension was freeze-dried. Powder was defatted adding hexane and stirring for 
1 h. The solvent was then recovered and powder was dried. 
 
M-SHIME® experiments 
Two Triple M-SHIME® models, inoculated with faecal samples of the same 
healthy donor, were performed in different times. The M-SHIME® contains, in 
addition to traditional luminal microbial community [34], some mucin 
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microcosms to host surface-attached microbes [35]. These microcosms (K1-
carrier, AnoxKaldnes AB, Lund, Sweden) are submerged in mucin-agar. The feed 
selected included (g/L): arabinogalactan (1), pectin (2), xylan (1), D-(+)- glucose 
(0.4), starch (4), yeast extract (3.0), peptone (1.0), and pig gastric mucin (4.0). At 
the start of each experiment, 500 mL of selected feed and 80 mucin-covered 
microcosms were added to proximal colon (PC) unit, while the distal colon (DC) 
unit was filled with 800 mL and the same amount of mucin. Subsequently, the 
inoculation was performed with 40 mL of a 1:5 dilution of fresh stools of a healthy 
human volunteer [36]. Three couples of colon vessels ran simultaneously, one for 
control, the other two for OP and PM treatment [Figure 1]. After an initial 
incubation of 18h for pH stabilisation, 140 mL nutritional medium and 60 mL 
pancreatic juice were supplied to each proximal colon compartment three times 
per day. The M-SHIME® was kept at 37 °C and anaerobic condition by flushing 
for 10 min with N2 every day. 
 
Figure 1 – M-SHIME® design 
After a stabilisation period of 2 weeks, daily doses of the extract were 
administrated in the PC vessel for 10 days. At the end of the treatment, a 4 days 
washout was carried out. Experiments were performed with different extract 
dosages, 4 g/L of OP and 2 g/L of PM. Three times per week, at the same time of 
the day, 20 mL of liquid sample were collected from each colon vessel [Figure 2]. 
1 mL was centrifuged and the pellet was stored at -20°C for DNA extraction. 




Figure 2 – M-SHIME® experiment 
 
HPLC/DAD/MS analysis 
Samples from proximal control vessels were added with fresh extracts at the same 
concentrations used for experiments, to evaluate starting point profiles 
(PCC_OLIVE and PCC_POME) for HPLC/DAD/MS analysis. These samples 
were then compared with proximal and distal samples recovered during treatment 
with extracts (PC1d9, DC1d9, PC2d9 and DC2d9). Samples of vessels content 
collected before the administration (PC1d0, DC1d0, PC2d0 and DC2d0) were also 
analysed to identify any possible interferences due to feed components. 
Samples were pre-treated in order to obtain a clear solution: 2 mL of luminal liquid 
from each sample were added with 0.5 mL of MeOH/Acetonitrile/Acetone in ratio 
1/1/1, then mixed with Vortex and kept at room temperature for 25 min as 
previously described [37]. Samples from vessels administrated with PM received 
the same treatment, but original supernatant was also acidified with HCOOH. The 
suspension was then centrifuged at 4°C, 5000 rpm, 10 min. 1 mL of supernatant 
was recovered and dried using N2 gas. The dried residue was dissolved in 200 µL 
of EtOH/H3O+ 70/30. Final ultracentrifugation (10 min, 14000 rpm) was applied 
to all samples before HPLC/DAD/MS analysis. 
Qualitative analysis were performed using a HP 1100 liquid chromatography 
(Agilent Technologies, USA) coupled with HP 6200 series MS/TOF. 
For OP treated samples a 150mm×3 mm i.d., 2.7 μm, RP-18, Poroshell column 
(Agilent Technologies, USA) was used. Eluents selected were (A) H2O at pH 3.2 
by formic acid and (B) CH3CN. The multi-step linear solvent gradient used was: 
0-40 min 5-40% B; 40–45 min, 40% B; 45–50 min 40–100% B; 50-53 min 100%; 
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53-55 min 100-5%, equilibration time 10 min; flow rate 0.4 mL/min. The UV-Vis 
spectra were recorded in the range 200–600 nm and the chromatograms were 
acquired at 240 nm, 280 nm, 330 nm, 350 nm. MS spectra were acquired using 
Dual-ESI source in negative polarity with 80 V fragmentor, 3800 V Capillary 
Voltage, 350°C of Gas Temperature. 
PM treated samples were analysed using a 150mm×2 mm i.d., 4μm, RP-18, 
Sinergi Fusion column (Phenomenex, USA). Same eluents used for OP were. The 
multi-step linear solvent gradient used was: 0-4 min 5-25% B; 4–8 min, 25–25% 
B; 8–14 min 25–35% B; 14-16 min 35-90%; 16-18 min 90-5%, equilibration time 
10 min; flow rate 0.4 mL/min. The UV-Vis spectra were recorded in the range 
200–500 nm and the chromatograms were acquired at 240 nm, 280 nm, 330 nm, 
370 nm, 380 nm. MS spectra were acquired using Dual-ESI source in negative 




Solvents and standards with analytical purity were purchased from SIGMA 
Aldrich. For SCFA analysis, a liquid-liquid extraction with diethyl ether was 
applied on frozen samples, after the addiction of H2SO4 and internal standard. 
SCFA quantitative analysis were performed by capillary gas chromatography 
coupled with a flame ionization detector (GC-FID), to measure acetic, propionic, 
butyric, isobutyric, caproic, isocaproic, valeric and isovaleric acids, as previously 
described [38]. 
NH4+ level was analysed by steam distillation according to Standard methods 
(4500-NH3 B; APHA, 1992). Determination of total ammoniacal nitrogen (TAN) 
in liquid luminal samples was performed through the quantification of NH4+ by 








Bacterial DNA from luminal samples was extracted as described earlier [39], 
using a Lysis Buffer (TrisEDTA, NaCl, PVP40, SDS, water) and glass beads for 
FastPrep. Extraction was performed with phenol-chloroform and EtOH/NaOAc 
was used for precipitation [40]. Samples were dissolved in TrisEDTA 1X and 
stored at -20°C. Concentration and quality were verified by Glomax Multi 
Detection system (Promega, USA) and 2% agarose gel electrophoresis. 
 
PCR-denaturing gradient gel electrophoresis (DGGE) 
In order to investigate potential composition changes in the microbial community 
a PCR-DGGE was assessed as seen previously [36]. PCR amplification for total 
bacteria of 16S rRNA gene was performed with primers 338F-GC and 518R and 
cycling conditions were: : initial denaturation 94 °C for 5 minutes; 30 cycles at 
95°C for 1 minute, 53°C for 1 minute; 72°C for 2 minutes and a final extension at 
72°C for 10 min [41]. 
PCR products were separated on denaturant gradient of polyacrylamide gel. 
DGGE (Denaturing Gradient Gel Electrophoresis) was performed [42] using the 
INGENY System (Ingeny International BV, The Netherlands). PCR fragments 
were loaded onto 8% polyacrylamide gels in 1´TAE buffer (Tris 1 acetate, EDTA 
pH 7.4). Polyacrylamide gels were made with 45-60% denaturing gradients. 
Electrophoresis was run for 16 hours at 60°C and 120 V. Staining and analysis of 
the gels were performed as described previously [43]. 
The normalization and analysis of DGGE gel patterns was done with the 
BioNumerics software 5.10 (Applied Maths, Sint-Martens-Latem, Belgium). In 
the process the different lanes were defined, background was subtracted, 
differences in the intensity of the lanes were compensated during normalization 






OP and PM composition 
Quantitative analysis were preliminary performed on PM and OP to evaluate the 
total content of polyphenols and fiber. Results are reported in Table 1. 
Polyphenols content of OP was evaluated in term of tyrosol, oleuropein and 
caffeic acid derivatives. Oleuropein derivatives resulted the most abundant, with 
a total concentration of 77.77 mg/g. Other polyphenols were characterized in OP, 
in particular hydroxytyrosol, verbascoside and luteolin. Total fiber content was 
defined according to standard methods for fiber determination and declared in 
label from the producer. 
The ellagitannins content was calculated in terms of α + β punicalagins, ellagic 
acid and its glycosides. α + β punicalagins resulted the main compounds (70.7 
mg/g), but ellagic acid was also well represented in the extract, with a 
concentration of 3.67 mg/g. Polysaccharides content was obtained adding two 
volumes of EtOH to original decoction and keeping the solution at 0°C for 3h, 















Total polyphenols 97.55 
PM 
α+β punicalagins 70.7 
Polysaccharides 
12% 
Ellagic acid and 
derivatives 
10.70 
Total ellagitannins 120.2 
Table 1 Content of polyphenols and fiber in OP and PM 
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Polyphenols metabolic fate 
Metabolic fate of main phenolic compounds was investigated by HPLC/DAD/MS 
analysis for both OP and PM. Samples collected from PC and DC at different 
time, a blank and a control with a fresh addition of extract from both experiments 
were treated in order to purify the solution for the analysis. Soluble proteins were 
precipitated and the clean supernatant was recovered and used for 
HPLC/DAD/MS analysis, aimed to point out any differences among samples 
profiles. 
According to chemical structure of the phenolic compounds in OP, two 
wavelength were selected to evaluate the metabolism of main components: 280 
nm (for tyrosol, hydroxytyrosol and derivatives) and 330 nm (for verbascoside 
and derivatives). According to Figure 3, the presence of hydroxytyrosol was well-
defined in control samples and identity was confirmed by MS spectra with [M-
H+] =153.16 m/z. After the treatment, the relative intensity of hydroxytyrosol 
strongly decreased and a new signal appeared in both PC and DC samples. m/z 
value of the new signal was 137.16, corresponding to tyrosol. The identity was 






Figure 3 – Chromatograms at 280 nm of control added with fresh extract (PCCOLIVE), and 
samples after treatment (PC1d9 and DC1d9). Two main compounds were detected: 
hydroxytyrosol (1) and tyrosol (2). 
 
 
Figure 4 – MS spectra of peaks detected in profiles at 280 nm showed in Fig.3 
 
Verbascoside, a typical phenyl propanoid of OP, was also metabolized. Despite 
the intensity of related signal in the control chromatogram, it disappeared in 
treated samples profiles and DAD did not record new peaks [Figure 5]. To 
investigate the metabolism of verbascoside, the structure of the molecule was 




in Figure 6. The exact mass of derivatives was calculated. Applying Extract Ion 
processing, two main compound were identified: caffeic acid (179.15 m/z) and 
tyrosol (137.16 m/z) were found in treated samples [Figure 7]. 
 
 
Figure 5- Chromatograms at 330 nm of the control added with fresh OP (PCCOLIVE), and 
samples after treatment (PC1d9 and DC1d9). Verbascoside (1) was identified in control 
sample, but not in other profiles. 
 





Figure 7 - MS spectra of peaks identified as verbascoside and caffeic acid. 
 
The same approach was applied to the PM samples, focusing on main compounds 
included in the extract, α and β punicalagins and ellagic acid. The wavelengths 
selected to investigate these molecules were 380 nm and 370nm, respectively, 
according to their maximum absorption wavelengths. 
On the other hand, punicalagins were not detected, probably due to their ability of 
arranging insoluble complexes with soluble protein, highly included in liquid 
luminal suspension. After the treatment, PC chromatogram appeared similar to the 
control one. The same signals were recorded; in particular, ellagic acid was still 
well defined and there was no clue of the presence of punilagins in the solution 
[Figure 8]. The presence of ellagic acid in control was confirmed by UV and MS 




Figure 8 - Chromatograms at 370 (A) and 280 (B) nm of control added with fresh PM 
(PCCPOME), and samples after treatment (PC2d9 and DC2d9). Ellagic acid (1) was 
identified in PCCPOME and PC2d9, but not in DC2d9 profile. Urolithin A (2) and Urolithin 






Figure 9 – MS spectra of peak identified as ellagic acid. 
 
Treated samples from DC showed a different profile. The signal of ellagic acid 
disappeared, while two new signals were recorded at 280 nm [Figure 8], with 
corresponding m/z values of 227.15 and 243.03 [Figure 10]. The molecules were 
identified as Urolithin A and Urolithin C [Figure 11]. These compounds are well-
known metabolites of ellagic acid, and it is very interesting how this metabolism 
worked only in the distal colon vessels. 
 




Figure 11 – Chromatogram at 280 nm and Extrac Ion profiles at [M-H+]: 243.03 m/z for 
Urolithin C and at [M-H+]: 227.15 m/z for Urolithin A from sample DC2d9. 
 
Polyphenols effects on microbial metabolism : SCFA and NH4+ 
Metabolic activity of bacteria was investigated through quantitative analysis of 
SCFA and NH4+ concentration. Results from the two experiments were processed 
as average and resulting charts are shown in Figure 12 and 13. 
SCFA average levels showed a quite regular trend in control vessels, except for 
the intrinsic variability of the system. Concentrations of DC samples were higher 
than PC ones, but the evolution was consistent. Similar behaviour was showed for 
NH4+ concentration in both DC and PC vessels. The system resulted quite stable 
with a weak variability. 
Samples from vessels treated with OP showed a trend comparable with control, in 
both proximal and distal vessels. No significant changes were recorded, even 
when the treatment was interrupted and after a 4 days washout. NH4+ 
concentrations were also linear during and after the treatment. 
In PC vessels treated with PM, a weak increase in SCFA levels was observed, 
with a decrease after administration interruption and a new increase - close to 




weak but not significant decrease of concentrations. NH4+ concentrations were on 
the other hand more regular during the treatment and the washout.  
 
Figure 12 – SCFA levels during and after treatment in PC and DC from control, PO and PM 
treated vessels. 
 





Polyphenols effects on microbial composition: PCR-DGGE 
measurement 
Different time point samples from the two experiments were selected to 
investigate the effects on the microbial community. PCR-DGGE for total bacteria 
was performed on samples collected before starting the treatment (Day 0), during 
and end of treatment (Day 5-9) and after washout (Day 13). 
DGGE pictures were processed with Bionumerics software in order to identify 
patterns and define a clusterization, as shown in Figure 14. 
Samples from control and vessels treated with OP formed a quite clear 
clusterization. Despite this, clusters showed high correlation values, meaning that 
no big differences were highlighted among samples. 
Referring to PM, clusterization was not well defined. Even in this case high 
correlation values were calculated and no significant changes in microbial 
community were stressed out. 
These results pointed out to a very selective and limited effect to low abundant 
microorganisms of the extracts on the microbiota composition, due probably to 






Figure 14 – Clusterization of DGGE patterns from starting point (d0), during and end of 




The experiments performed to investigate mutual effects of microbial community 
and polyphenols took into account different parameters, to obtain more complete 
information. 
The metabolic fate of polyphenols was the main aspect investigated in this study: 
secoiridoids and phenyl propanoids presence was evaluated for OP, while the 
ellagitannins were studied for PM samples. It is important to understand how these 
molecules should affect the metabolism they usually undergo depending on 
microbiota, since these transformations are a clear clue of microbial wellness. At 
the same time, it is needed to evaluate which metabolites are produced. It is 
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established that, at colon level, there is the maximum absorption of phenolic 
compounds and their derivatives [25,26], but not all metabolites maintain the same 
positive effects of the original molecules. OP content was first evaluated, 
identifying two main molecules, hydroxytyrosol and verbascoside. These 
compounds own positive effects, like anti-oxidant, anti-inflammatory, 
antimicrobic, anti-atherosclerotic, anti-hypertensive effects [45–52]. Therefore, a 
complete metabolism was detected in PC and DC, demonstrating the normal 
activity of microbiota. Moreover, the molecules identified as derivatives were 
tyrosol and caffeic acid, that also showed many beneficial properties, such as 
antioxidant, anti-inflammatory, anti-atherogenic and chemoprotective [53–55]. 
Referring to PM, the first result was the absence of punicalagins, the main 
components of pomegranate juice and mesocarp. In literature the capability of 
these compounds to complex soluble protein and produce precipitate is already 
reported [56]. According to this property, it is possible then to assume that they 
are involved in this reaction, due to high protein content in the feed selected for 
the experiments. Ellagic acid turned out to be the main component in control 
sample, and its metabolites were not detected in PC, but were identified in DC, 
where new signals appeared and urolithinsA and C were identified. Even in this 
case, the obtained result is consistent with previous in vivo studies that showed 
the metabolic path of ellagic acid to urolithins in the distal tract of intestinal 
system [30,31]. These resulted confirmed also the ability of SHIME® system to 
well simulate the human metabolism of specific intestinal regions. 
Microbial functionality was then investigated. Since polyphenols could affect 
various bacterial functions, levels of SCFA, derived from sugars fermentation, and 
NH4+, proteolysis index, are usually quantified to evaluate the activity of microbial 
community. In duplicated experiments, both materials did not show any 
significant effects on normal levels. Compared to PC and DC from control, 
samples administrated with OP and PM showed a regular trend of SCFA and 
NH4+, with concentrations comparable with those of control. Few variations were 
recorded, but they were too weak to be considered significant. For this reason, it 
can be assessed that the selected products do not affect microbial functionality. 
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In addition to previous results, also a PCR-DGGE for total bacteria and relative 
data processing through Bionumerics were performed to obtain qualitative 
information on microbial composition. High correlation values calculated for 
comparison among control and treated samples, demonstrated that the overall 
composition did not change significantly after the treatment, maintaining similar 
pattern and distribution. These results confirmed that the low concentrations of 
phenolic compounds in selected by-products are not able to affect and modulate 




In this study we demonstrated that the use of by-product derived from olive and 
pomegranate, containing medium amount of polyphenols, did not provide any 
significant change in colon microbial community and functionality. The products 
did not provide positive effects in addition to a normal diet, but at the same time 
no negative impact was detected. According to these results, OP and PM resulted 
as good candidates to be included in food supplements or to be used as excipients 
in nutraceutical formulations. They can be considered a vehicle for a further intake 
of polyphenols and beneficial metabolites, associated with fiber and 
polysaccharides which could provide also prebiotics effects. 
Further investigation are necessary to understand the real bioavailability of main 
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[51] Díaz AM, Abad MJ, Fernández L, Silván AM, De Santos J, Bermejo P. 
Phenylpropanoid glycosides from Scrophularia scorodonia: In vitro anti-
inflammatory activity. Life Sci 2004;74:2515–26. 
doi:10.1016/j.lfs.2003.10.008. 
[52] Kang DG, Lee YS, Kim HJ, Lee YM, Lee HS. Angiotensin converting 
enzyme inhibitory phenylpropanoid glycosides from Clerodendron 
trichotomum. J Ethnopharmacol 2003;89:151–4. doi:10.1016/S0378-
8741(03)00274-5. 
[53] Nardini M, Pisu P, Gentili V, Natella F, Di M, Piccolella F, et al. Effect of 
caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937. 
Free Radic Biol Med 1998;25:1098–105. doi:10.1016/S0891-
5849(98)00180-4. 
[54] Meyer AS, Heinonen M, Frankel EN. Antioxidant interactions of catechin, 
cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL 
 
129 
oxidation. Food Chem 1998;61:71–5. doi:10.1016/S0308-8146(97)00100-
3. 
[55] Quiles JL, Farquharson AJ, Simpson DK, Grant I, Wahle KWJ. Olive oil 
phenolics: effects on DNA oxidation and redox enzyme mRNA in prostate 
cells. Br J Nutr 2007;88:225. doi:10.1079/BJN2002620. 
[56] Quideau S, Deffieux D, Douat-Casassus C, Pouységu L. Plant 
polyphenols: chemical properties, biological activities, and synthesis. 















Food supplements with high polyphenols content are widely used. The properties 
of phenolic compounds were defined through many studies in in vitro and in vivo 
models. However, after oral administration these molecules can suffer many 
metabolism, in particular due to intestinal microbial communities (microbiota). 
Microbiota activity could be also influenced by phenolic compounds, which can 
interact with bacterial cells using many mechanisms. 
In this work, we evaluated the mutual influence between polyphenols and 
intestinal microbiota, considering different aspects: polyphenols metabolic fate by 
HPLC/DAD and HPLC/MS-TOF, microbial functionality measuring Short Chain 
Fatty Acids (SCFA) and NH4+ levels, and microbiota composition by PCR-DGGE 
/ Illumina sequencing. All studies were performed reproducing a continuous oral 
administration in the in vitro gastrointestinal simulator M-SHIME®. 
 
Three main studies were conducted, using different botanicals, with various 
classes of phenolic compounds, and applying different experimental conditions. 
 
The first study was performed with Vineatrol®, a commercial extract from grape-
vine with high content of trans-resveratrol and other stilbenoids. The results 
obtained from the experiment showed that a daily administration of the extract 
provides negative effects on microbiota. The polyphenols metabolism, due to 
bacteria, works normally in the first 24h, but it seemed arrested with continuous 
dosages. The same evolution was observed for microbial functionality and 
microbial composition was also affected during the treatment. Daily intake of 
Vineatrol® led to a negative affection of intestinal balance. The result is very 
interesting, because to date, no significant studies were reported on the effects of 




The other two studies were performed on botanicals recovered from food by-
products: an olive “pâté” from extra virgin olive oil production and a pomegranate 
mesocarp decoction. 
Polyphenols content was determined in both materials and resulted lower than 
Vineatrol®. They were used for tests in vitro, simulating a daily intake of food 
supplements for 9 days. 
Administration in addition of normal diets showed that the extracts did not provide 
significant changes to basic metabolism, functionality and microbial composition 
in colonic region. Moreover, polyphenols metabolization observed in the 
experiment was consistent with results from in vivo studies, confirming a normal 
activity of microbial communities. This result is interesting since these materials, 
recovered from food processing in large amount, could be used as ingredients of 
food, dietary supplements or nutraceutics, as delivery vehicle of polyphenols and 
fiber at colon level. 
 
A second experiment was performed for administration of the same extracts, using 
different feed to investigate potential benefits of daily intake of these by-products 
also in extreme conditions. To this aim a sugar free diet with high protein content 
was selected  
Positive effects were recorded for the administration with this feed highlighting 
an increase of SCFA levels. According to well-known biological properties of 
SCFA, it is possible to improve intestinal wellness and contrast any adverse 
consequence of this kind of diets, which usually leads to inflammatory states. 
Moreover, the high content of polyphenols, found in olive and pomegranate 
wastes, could help to ameliorate the overall conditions, due to the several 
beneficial activities recognized to phenolic compounds. 
 
All performed experiments showed that it is important to consider many 
parameters. 
First, the concentration of the extract is certainly a crucial aspect, since repeated 
doses could lead to negative effects on intestinal balance. Furthermore, the dietary 
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conditions are strongly related to potential activities of polyphenols and fiber 
included in vegetable extracts. 
More information about bioavailability of phenolic compounds are still required 
to improve administration method and period. 
Anyway, it was assessed that the in vitro system M-SHIME® can be a useful and 
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Pomegranate (Punica granatum L.) fruit has been used extensively in the folk 
medicine of many cultures. This fruit is well known for its ellagitannin content 
but it also contains polysaccharides that have not yet been thoroughly investigated. 
Antioxidant and antiglycation activities have been reported for a polysaccharide 
of pomegranate peel and anticancer activity in mice for a galactomannan 
recovered from the fruit’s rind. To date scant data have been published on the 
optimization of extracting the polysaccharides, the main by-products of juice 
production, from the mesocarp and exocarp. Furthermore, no data are available 
on the prebiotic properties of the polysaccharides recovered from pomegranate 
fruit. The aims of this study were to determine the amount of crude 
polysaccharides (CPS) in the mesocarp and exocarp of the Laffan and Wonderful 
pomegranate cultivars,  to optimize the extraction process in terms of shorter time 
and higher yield of CPS, to determine the sugar composition and molecular shape 
of the main components, and to evaluate the prebiotic properties by in vitro testing 
on Bifidobacterium and Lactobacillus strains. 
The maximum extractive yields in terms of crude polysaccharides (10% w/w dried 
matter (DM)) were achieved with a dried matter/solvent ratio of 1:40 (w/v) and 
through water decoction for 60 min. The two varieties showed similar profiles in 
terms of polysaccharides and similar amounts, with the highest concentration in 
the mesocarp. These CPS were able to absorb up to 99.1% of water-confirming 
their potential use as gelling agents in food chemistry. 
To the best of the authors’ knowledge, this is the first report demonstrating how 
CPS from the Laffan and Wonderful pomegranate mesocarp can sustain growth 
of beneficial and potentially probiotic bacteria such as those used in this study 
and, therefore, possess prebiotic properties. 
 
 




Polysaccharides are a class of biological macromolecules with huge structural 
diversity that are relatively common in nature, and thus their biological properties 
have attracted substantial attention in medicine (Ooi & Liu, 2000; Sinha and 
Kumaria, 2001). Natural polysaccharides are known as thickeners, gelling agents, 
carriers of hydrophobic drugs and base products for preparation of nanoparticles 
and skin care products. They also are extensively used in the design of drug 
delivery systems, due to their excellent biocompatibility, aqueous solubility, and 
stability (Bhardwaj et al., 2000; Liu et al., 2008;Marathe, et al., 2002; Rubinstein, 
2000; Deters, et al., 2001; Wang and Fang, 2004). Polysaccharides have proven 
to be useful candidates in the search for effective, non-toxic natural substances 
with pharmacological effects and represent a relatively untapped source for new 
drugs, which may provide novel therapeutic opportunities (Beat and Magnani, 
2009). Several polysaccharides with in vitro antitumor effects have been isolated 
from plants, mushrooms, yeasts, algae, and lichens; most of them have been found 
to be non-toxic to normal cells and they are often able to enhance the immune 
system of the host (Mahady, 2001, Leung, et al. 2006) or to act as biological 
response modifiers. To date, several natural polysaccharides have been proven to 
exert antioxidant, antitumor, immunomodulatory, antimicrobial, antiulcer and  
hypoglycemic activities (Franz, 1989; Liu, et al., 1997; Kardošová and Machová, 
2006; Schepetkin and Quinn, 2006; Ooi and Liu, 2000; Zhu et al. 2013; Xie et 
al.,2010). 
Some  polysaccharides introduced through the diet can have prebiotic activity, i.e. 
they can stimulate the growth of beneficial bacteria in the colon, thereby 
contributing to the healthy status of the gut (Marotti, et al. 2012; Di Gioia, et al. 
2014b). The intestinal tract harbors a complex bacterial community which has a 
great impact on the nutritional and health status of the host (Laparra and Sanz, 
2010). A balanced gut microbial composition confers benefits to the host, due to 
the modulation of metabolic and immune functions, while microbial imbalances 
are associated with metabolic disorders and/or disease (Tremaroli and Backhed, 
2012; Di Gioia et al. 2014a). Therefore, the maintenance of a correct equilibrium 
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between beneficial microorganisms, mainly belonging to the Bifidobacterium and 
Lactobacillus genera, and potentially pathogenic strains, is crucial for host health. 
The presence of abundant Bifidobacteria and Lactobacilli may provide some 
protection against incoming enteric pathogens (Jankowska et al. 2008, Symonds 
et al. 2012). They are able to compete for nutrients with enteric pathogens, to 
adhere strongly to the intestinal mucosa, thus preventing pathogen adhesion and 
to stimulate the development of the mucosal immune system. 
Pomegranate (Punica granatum L., family of Punicaceae) has been used 
extensively in the folk medicine of many cultures (Li et al., 2006) and has a wide 
range of potential clinical applications involving its antitumor, antibacterial, 
antidiarrheal, antifungal, and antiulcer properties  (Valadares et al., 2010). 
Researchers have pointed out the main role played by ellagitannins as principal 
bioactive constituents of the different extracts obtained from the pomegranate 
fruit. In general, most of the studies on the pomegranate are characterized by a 
lack of attention toward the extraction and characterization of the polysaccharide 
fractions recovered from the different parts of the fruit. One study has reported 
that a polysaccharide from pomegranate peel shows significant antioxidant, 
antiglycation and tyrosinase inhibition properties (Rout and Banerjee 2007). A 
more recent study on galactomannan, a polysaccharide recovered from the fruit 
rind of P. granatum, shows that this molecule exerts cytotoxicity, 
immunomodulatory, and free radical scavenging activities in  in vitro tests (Joseph 
et al., 2012), but also has anticancer activity in mice, enhancing survival and 
reducing the tumor either alone or in combination with doxorubicin (Sreelekha et 
al., 2008; Joseph et al., 2013). This study provides evidence of the non-toxic 
nature of this plant-derived compound, which could be used as an adjuvant or as 
a single agent for the treatment of cancer (Joseph et al., 2013). Other authors (Li 
et al., 2014) report that polysaccharides from pomegranate peel inhibit the 
proliferation of U-2 human osteosarcoma cancer cells by inducing apoptosis 
mainly through a mitochondrial signaling pathway. 
Up to now, most of the reports have focused on pomegranate peel, which is 
reported to constitute 45-50% of the fruit’s total weight. Nevertheless with this 
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term authors often mean the sum of the exocarp (the real peel) and mesocarp (Negi 
et al., 2003; Pan, et al., 2012; Saad et al., 2012; Al-Said et al., 2009; Levin, 2006) 
without making a real distinction between the two parts of the fruit. To date, the 
mesocarp and exocarp of the pomegranate, as the main by-products of juice 
production, have not been well investigated as a potential source of bioactive 
constituents, in particular polysaccharides, and no data are available on the 
possible prebiotic properties of these polymers.  
The objectives of this study were to optimize the extraction process of 
polysaccharides from the mesocarp and exocarp of Laffan and Wonderful 
pomegranate cultivars , to determine sugar composition and the molecular shape 
of these polymers and to evaluate their prebiotic properties through in vitro testing 
on strains belonging to the Bifidobacterium and Lactobacillus genera. 
 
Experimental Part  
Materials 
The Laffan cultivar (sour-sweet) was harvested from Rif Idlib-Syria in October 
2011; the Wonderful cultivar was purchased from Ortofrutta Grosseto (Italy) in 
October 2013. About 5-7 kg of fresh ripe fruits of both cultivars were used as the 
source of exocarp and mesocarp to extract the polysaccharides.  
 
Sample preparations and extraction processes 
The exocarp and mesocarp were manually separated from fresh pomegranate 
fruits, then cut into small pieces and freeze-dried. To recover the polysaccharides, 
both parts were powdered in a grinder immediately before extraction, applying the 
methods described below. In this text, the term “dried matter” (DM) refers to the 
dried weight of the mesocarp and exocarp.  
Hot water extractions were performed on coarse powdered material, which was 
boiled in distilled water under stirring for 30 or 60 min and by carrying out one or 
two successive extractive steps indicated in Table 1 (M-1 and M-2). After boiling, 
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each sample was cooled and centrifuged at 4500 g for 8 min at 4°C, in order to 
collect the supernatant containing the polysaccharides. The M-2t-p differs from 
M-2t only because of pre-treatment of the DM, to which water was added and then 
stirred at 25°C for 12 h before the hot water extraction.  
Extractions were also performed (M-3r and M-3l) at room temperature, whereby 
the DM was soaked in distilled water (1 g DM/40 mL), then stirred for 24 h and 
filtered through Whatman filter paper to obtain the solution containing the 
polysaccharides. A modification of M-2s was made by reducing the water volume 
(1 g DM/25 mL) in the extractive ratio and obtaining M-4s-p. At the end a batch 
test was carried out applying a pretreatment before the decoction: 70% ethanol  
v/v was added to the powder (ratio 1 g DM/40 mL), the sample was stirred at room 
temperature for 24 h, then filtered through Whatman filter paper. The solid residue 
was treated with water (ratio 1 g DM/25) and a single decoction of 60 min was 
applied (M-5s-Et).  
Each solution, obtained after centrifugation according to the methods summarized 
in Table 1 was added with 2 volumes of ethanol and kept 3 h at 0 °C, to induce 
the precipitation of the polysaccharides recovered after a centrifugation at 4500 
rpm for 12 min at 5 °C. 
 
Procedures to obtain crude polysaccharides (CPS) and purified 
polysaccharide (PPS). 
Two different procedures were applied to remove part of the ellagitannins and to 
eliminate the proteins. All the polysaccharides shown in Tables 1 and 2 were 
washed with distilled water, than 2 volumes of ethanol were added and the 
samples kept 3 h at 0 ◦C. The precipitates were recovered after centrifugation 
(4500 rpm, 12 min at 5 °C), then frozen and freeze-dried to obtain the crude 
polysaccharides (CPS). Total recovery has been expressed as % yields of CPS on 
DM. The proteins were removed according to Joseph et al., (2012). Briefly CPS 
were dissolved in water then added with chloroform, and a liquid/liquid extraction 
was repeated several times until the water chloroform inter-phase became clear; 
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the aqueous phase containing the purified polysaccharide (PPS) was recovered 
and freeze-dried. 
 
Filtration by cut-off filter of PPS 
Freeze-dried PPS were re-dissolved in water, then 500 µl of this solution were 
transferred into an Amicon ultra-filter device (cut-off 10,000 Daltons) and 
centrifuged at 14,000 x g for about 15 min. The precipitate was reconstituted with 
the original water volume; the process was repeated up to 7 times, as indicated by 
the supplier, to remove about 99% of fouling, low molecular weight materials and 
salts, from the sample. After these cleaning steps, the filter device was placed 
upside down in a clean microcentrifuge tube for 2 minutes at 1,000 x g; 500 µl of 
distilled water were then added to dissolve the purified polysaccharide and the 
recovered solution to obtain the PPSA sample. 
 
Determination of the monosaccharide composition of PPS 
PPS and PPSA, derived through the purification steps of Laffan and Wonderful 
mesocarp and exocarp (from M-2s), were hydrolyzed according to Erbing et al. 
(1995). Briefly, a 2 M solution of trifluoroacetic acid (1 mL) was added to the PPS 
and PPSA (5 mg), maintained at 120°C for 120 min, cooled on ice, then 
ultrafiltered at 3500 x g for 20min using centrifuge filter devices (Amicon ultra) 
having a cut-off of 3,000 Daltons, and the supernatant was dried in a rotavapor. 
The samples were washed twice with MilliQ-grade water, re-dissolved in 1 mL 
deionized water and then analyzed by ion exchange chromatography. The 
instrument used was a Dionex ICS-2500 ion chromatograph (Sunnyvale, CA) with 
an ED50 pulsed amperometric detector using a gold working electrode (Dionex, 
Sunnyvale, CA); the column was a Carbopac PA1 4 mm by 250 mm (Dionex, 
Sunnyvale, CA). The eluents used were MilliQ-grade water (solution A), 0.185 M 
sodium hydroxide solution (solution B), and 0.488 M sodium acetate solution 
(solution C). A gradient elution was used consisting of a first stage (injection time 
to the 7th min) with an eluent constituted by 84% solution A, 15% solution B, and 
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1% solution C; a second stage injection time from the 7th to 13th min) with 50% 
solution B and 50% solution C; and a final stage (injection time from the 13th to 
the 30th min) with 84% solution A, 15% solution B, and 1% solution C. The flow 
rate was 1 mL min-1. The monosaccharides were detected according to retention 
time of standards purchased from Sigma-Aldrich (Milan, Italy). 
 
Molecular shape size determination by Size Exclusion 
Chromatography (SEC) 
PPS extracted from Laffan and Wonderful pomegranate mesocarp and exocarp, 
separately, were weighed and dissolved in distilled water. After homogenization, 
the suspension was analyzed using a Varian ProStar HPLC chromatograph 
(Varian, USA) equipped with a 355 refractive index (RI)  detector and a column 
for Size Exclusion Chromatography (SEC), Biosep s4000 (Phenomenex, USA). 
Samples were analyzed with runs of 30 min with HPLC-grade water as eluent at 
a flow rate of 0.6 mL min-1, using Dextran (Sigma-Aldrich, USA) at different 
molecular weights (MWs) (Blue dextran approx. 2000 kDa, 1100 kDa, 410 kDa, 
150 kDa and 50 kDa) as standards. 
 
In vitro evaluation of the prebiotic activity of CPS  
The capability of CPS of stimulating the growth of beneficial bacteria (prebiotic 
activity) was assayed using two strains previously isolated from human feces: 
Bifidobacterium breve B632 (Aloisio et al. 2012) and Lactobacillus plantarum 
L12. The latter was isolated from a healthy human (unpublished results) and 
taxonomic characterization was performed via 16S rDNA amplification and 
sequencing (Gaggia et al. 2013); this strain is available at the Bologna University 
Scardovi Collection of Bifidobacteria. Both strains were stored in lyophilized 
form. When necessary, they were re-vitalized in de Man Rogosa Sharpe (MRS) 
medium (Oxoid, Basingstone, UK) supplemented with 0.05% cysteine and 
incubated in anaerobic conditions at 37°C for 24 h. Anaerobic conditions were 
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created in a capped jar using an anaerobic atmosphere generation system 
(Anaerocult A, Merck, Darmstadt, Germany). 
The MRS medium composition was modified to perform the growth experiment 
with the pomegranate polysaccharides. The modified medium (m-MRS) did not 
contain the carbon source (glucose), which was provided by the pomegranate 
polysaccharide, and had a halved amount of potential growth substrate, such as 
peptone, yeast extract and meat extract compared to those present in the original 
medium (peptone, 5 g/L; yeast extract, 2 g/L, meat extract 5 g/L were the amounts 
in m-MRS). 
The prebiotic activity was evaluated using CPS at 0.5% (w/v) in m-MRS. A 
positive growth control was performed using m-MRS with 0.05% glucose and a 
negative control in m-MRS with no added carbon source. The medium containing 
CPS as the carbon source was prepared as follows: the m-MRS ingredients were 
weighed in a flask, dissolved in water and the medium was autoclaved at 120°C 
for 15 min. 0.5% (w/v) fiber or glucose at the same concentration were added to 
the hot medium, stirred, and sterilized again at 102°C for 10 min. This procedure 
allowed the fiber to dissolve in the medium and, at the same time, could prevent 
risk of growth of undesired microorganisms. The B. breve B632  and L. plantarum 
M12 strains were grown overnight in the respective media, centrifuged, washed 
in phosphate buffered saline (PBS) and re-suspended PBS to obtain a solution 
having an absorbance of 0.7 at 600 nm. This suspension was used to inoculate at 
2% (v/v) the flasks containing the m-MRS medium plus the fiber, the m-MRS 
medium plus glucose (positive control) and the m-MRS medium with no 
additional carbon source (negative control). The flasks were incubated at 37°C in 
anaerobic conditions for 48 h and 1 mL culture was sampled from each flask for 
viable bacterial counts at pre-established times (0, 6, 24, 30 and 48 h of 
incubation). The sampled amount was mixed with 9 mL of PBS, serially diluted 
in the same solution and plated on agarized MRS supplemented with cysteine. 
Following incubation of the plates at 37°C in anaerobic conditions for 24 h, the 
number of colonies, corresponding to the number of viable cells, was counted. 
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The number of cells expressed as CFU/mL were transformed to Log10 value (Log 
CFU/mL). 
 
Results and Discussion 
Recovery of polysaccharides: preliminary evaluation 
In recent decades, plant polysaccharides have attracted a great deal of attention in 
the biomedical field due to their wide spectra of therapeutic properties and 
relatively low toxicity. Nevertheless, little attention has been addressed to 
polysaccharides from pomegranate fruits which are mostly known as a good 
source of anthocyanins and ellagitannins but hardly cited for their polysaccharide 
content. One of the most common methods for recovering these polymers from 
different sources is the use of hot water, then collection of supernatant and 
recovery of the precipitated polysaccharides after addition of ethanol (Huie and 
Di, 2004; Joseph et al., 2012 ; Zhu and Liu 2013). In our study a similar procedure 
was applied to the mesocarp and exocarp separately, to evaluate their 
polysaccharide content. The first goal was to select efficient extractive procedures 
using the Laffan cultivar mesocarp as reference material. Later, the recovered 
polysaccharides were purified, analyzed to determine their sugar composition and 
molecular size and some of them were used for an in vitro evaluation of their 





Figure 1. Chart to summarize all the analyses applied to the polysaccharides 
 
Table 1: Methods  to recover CPS from Laffan mesocarp and corresponding extractive 
yields (mean values as w/w DM); *tests were carried out in triplicate. s =single step ; t =two 
consecutive steps; r= rapid extraction; l= long extraction; p= preliminary contact with dried 





DM (g)/  
solvent (mL) 
T (°C) Time (min) Yield (%)  
M-1s 1/15 100 30 5 
M-1t 1/15 100 30+30 8 
*M-2s 1/40 100 60 10 
*M-2t 1/40 100 60+ 60 9.8 
*M-2t-p 1/40 100 60+ 60 9.1 
*M-3r 1/40 25 720 2.0 
*M-3l 1/40 25 1440 3.3 
*M-4s-p 1/25 100 60 7.8 
*M-5s-Et 1/25 100 60 7.15 
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In regard to extraction, three independent parameters, extraction time (h), 
extraction temperature (°C) and ratio DM/water, were modified during this study 
to increase the extractive yields and Table 1 summarizes the preliminary results 
obtained for the Laffan cultivar mesocarp First, 30 min or 60 min were set as 
extractive time in a single or two successive steps, using hot water as elective 
solvent (methods 1-2). In one case DM was previously extracted through a 
hydroalcoholic solution (M-5s-Et) and then treated with hot water according to 
the study of Tong et al. (2009)  An aqueous extraction at room temperature was 
also performed (M-2t-p) as proposed by other authors (Li et al., 2007) for 
pomegranate. The ratio between DM and extractive solvent varied from 1:15 w/v 
for M-1, to 1:25 w/v for  M-4s-p and M-5s-Et, with a maximum of 1:40 w/v for 
the M-2 and M-3. The best extraction processes were selected by evaluating the 
percentage yields of CPS recovered from DM. 
To remove part of the impurities co-precipitated after the first ethanol addition 
(see Chart in Fig. 1) the recovered polysaccharides (PP) were re-dissolved in water 











Table 2:Polysaccharides content (CPS) in mesocarp and exocarp of Wonderful and Laffan. 





CPS on DM 
mesocarp 
Yield (%) 
CPS on DM 
exocarp 
M-2s 
Laffan 9.80±0.28 4.47±0.50 
Wonderful 8.0±0.10 4.7±1.15 
M-3l 
Laffan 3.7±0.42 1.93±0.23 
Wonderful 3.33±1.15 1.99±0.02 
M-4s-p 
Laffan 7.80±0.28 4.20±0.20 
Wonderful 5.67±0.58 4.13±0.31 
M-5s-Et 
Laffan 7.15±0.21 3.93±0.12 
Wonderful 6.70±0.66 4.07±0.31 
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To verify if this stage was effective in cleaning the polysaccharides, the amount 
of the impurities was evaluated by weighing the dried discarded solutions 
recovered after the 2nd addition of ethanol. The amount of these impurities was 
5.4% and 7.4% of dried mesocarp for Wonderful and Laffan, respectively, while 
these residues were close to 3% DM for both the cultivars in the exocarp. These 
results indicate that the 2nd addition of ethanol appeared necessary to obtain a more 
purified fraction (CPS) from the first precipitated sample (PP). Moreover, taking 
into account the presence of a high amount of ellagitannins (ETs) in pomegranate 
fruit, an HPLC/DAD analysis (Khatib, 2015) was applied to estimate the amount 
of ETs loss, because co-precipitated in the PP sample. To this aim, the washing 
solutions recovered during the precipitation of CPS were dried, re-dissolved and 
analyzed. Globally, it emerged that low amounts of ETs were trapped in the 
precipitated polysaccharides, substantially not over 1.1% and 0.4 % of DM 
respectively for the mesocarp and exocarp of both the cultivars.  
Applying the same extractive ratio of 1:15 (w/v), the yield in CPS increased from 
5% (M-1s) to 8% (M-1t) when the extraction time was extended from 30 min to 
60 min. As shown in Table 1, the maximum yield of 10% was obtained with an 
extractive ratio of 1/40 (w/v), and by applying a single extraction of 60 min (M-
2s). A successive step (M-2t) of 60 min, as well as previous contact of the DM 
with the water medium before boiling (M-2tp), did not increase the final recovery 
of CPS.  
After this pre-screening, a time of 60 min was selected for decoction and applied 
to the mesocarp and exocarp of both cultivars to obtain  the samples listed in Table 
2. The mesocarp yields were up to 7.8% and 5.7% for Laffan and Wonderful 
cultivars, respectively. The best procedure in terms of CPS percentage was from 
M-2s, also showing good reproducibility of the extractive process with a 
maximum RSD value of 2.8%. Applying an extractive ratio of 1:25 (w/v), lower 
amounts of CPS (close to 7% in Table 1) were recovered.  These values are in 
agreement with those reported by Zhu and Liu (2013) for pomegranate peel 
purchased from a local Chinese market and treated in a similar mode, although  
the authors did not clarify if the term “peel” referred to both peel and mesocarp 
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together. In a recent study on yield  of polysaccharide from pomegranate peel, was 
13.658 ± 0.133%, from pomegranate fruit purchased from a local Chinese local 
market  and  was extracted  the ultrasound-assisted  ( Zhu et al  .2015). 
During this screening extraction was also carried out at room temperature as 
proposed by Li et al. (2007). As expected, the recovery was considerably lower 
and below 3.5%, even when allowing contact time between DM and water of 
between 12 h (M-3r) and 24 h (M-3l). In conclusion, by trying to avoid the co-
precipitation of small amounts of ETs in PP (as in Figure 1), a pretreatment with 
ethanol 70% v/v at room temperature for 24 hours was made before the decoction 
(M-5s-Et). The yields in CPS were lower if compared with those derived by M-2s 
but this approach can be usefully applied if the objective is to efficiently recover 
the ellagitannins before the precipitation of polysaccharides, as previously 
demonstrated (Khatib , 2015).  
Taking into account the results summarized in Table 1, only some methods were 
selected to treat the four different dried materials. Overall, similar results were 
obtained for the two cultivars, pointing out that the M-2s was the best procedure, 
of the tested methods, in terms of % yields, while M-3l carried out at room 
temperature was the worst one (Table 2). In agreement with other literature data 
(Yin and Dang, 2008; Sun Li, et al., 2010; Sun Liu, et al., 2010), the use of hot 
water increases polysaccharide solubility and extractability and was determinant 
for maximizing the recovery of CPS, but the same extraction at room temperature 
is always less efficient. 
We verified that CPS were also localized in the exocarp of the fruit but in lower 
amounts than in the mesocarp, with maximum values between 4.5-4.7% for both 
cultivars (M-2s). As expected, the CPS percentage recovered from the exocarp 
had a higher variability (RSD from 11% to 25%) mainly due to the non-
homogeneous thickness of the raw material that may contain different amounts of 
residual parts of mesocarp, which are difficult to completely remove. The 
decoction carried out after a previous extraction with ethanol/water (7:3v/v) 
provided CPS amounts close to 4% for both cultivars, and similar to those derived 
from M-2s. On the other hand, the lowest recovery was derived by extraction at 
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room temperature (M-3), in agreement with the results obtained for the mesocarp 
and with those reported by other authors employing an analogous extraction from 
the rind (Rout and Banerjee, 2007). 
 
Sugar composition by hydrolysis  
Samples were treated with trifluoroacetic acid to hydrolyze the polysaccharide 
strands and subsequently determine sugar composition by ion exchange 
chromatography according to previous methods (Erbing et al,. 1995). The 
composition of four purified polysaccharide fractions are reported in Table 3. On 
the whole, diverse monosaccharides were found, and these samples showed a very 
similar composition for both the cultivars. Within the hexoses galactose, 
glucose/mannose, and fructose; then aldopentose arabinose, pentose xylose, 
deoxysugar rhamnose and galacturonic acid were found (Table 3). Glucose and 
mannose, having very close retention times, were co-eluted in one peak on the 
chromatograms. In the entire analyzed sample, glucose, xylose and glucuronic 
acid were the most abundant sugars (Table 3).  
 
Table 3: Sugar composition of PPS obtained by acid hydrolysis (Erbing et al.. 1995). 
m, mesocarp;  e,  exocarp; L, Laffan  and W,  Wonderful. 
Normakhmatov et al. (1999) pointed out that the main monosaccharides in the 
water-soluble polysaccharides from pomegranate peel varied with the growth site, 
 Molar % 
Sugars PPS-mW PPS-mL PPS-eW PPS-eL 
Rhamnose 10.4 7.2 10.8 10.1 
Arabinose 4.52 4.04 4.88 4.08 
Galactose 5.91 7.31 7.34 7.05 
Glucose 14 10.3 11.5 10.9 
Xylose 11.2 7.87 9.36 9.3 
Fructose 0.41 0.29 0.17 0.2 
Galacturonic 
acid. 
53.8 63.1 56 58.37 
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and were constituted by glucose, galactose and xylose, with larger amounts of 
xylose, arabinose and galactose detected in the peel of other varieties of 
pomegranate harvested in different growth sites. In another study the composition 
of a polysaccharide from pomegranate peel showed glucose at 52.8% and 
glucuronic acids at 33.5%. Other monosaccharides included arabinose and  
galactose close to 5.0%,  mannose and rhamnose close to 1.6% and only 0.5% for 
xylose. (Jahfar et al., 2003). 
From the few reports available to date on polysaccharides of pomegranate fruits, 
it emerges that there is a certain variability in the sugar composition that is mainly 
related to the variety and growth site but is also affected by the different purity 
grade of the polysaccharide itself, as analyzed by various authors. Notably, the 
two cultivars (one mainly localized in Syria and the other widely diffused 
throughout the western world) showed a very similar compositional profile of the 
polysaccharides. However, this result is not completely unexpected, and is in 
agreement with a previous document that hypothesized that the Wonderful variety 
is derived from the more ancient Laffan cultivar (Goor, 1967). 
 
Filtration by 10,000 Dalton cut-off 
In order to purify the CPS, the efficiency of ultrafiltration devices was tested on 
the samples obtained from mesocarp (Table 2). The recovered solid material 
obtained after ultrafiltration was submitted to acidic hydrolysis to evaluate the 
monosaccharidic composition. It emerged that the CPS samples before and after 
the cut-off filtration provided the same results in terms of molar percentage for all 
the sugars (data not shown), meaning a substantial absence of impurities 
represented by free oligosaccharides in the CPS. These results suggested that the 
samples listed in Table 2 did not need further purification by this filter device 





Molecular size of polysaccharides 
The CPS from mesocarp and exocarp of the two cultivars were analyzed by SEC 
to determine their dimension. Since these polymers may be characterized by a 
branched structure, often related to the presence of arabinose, galactose and 
xylose, the determination of the size by SEC was elaborated in terms of 
hydrodynamic volume, and not in terms of actual molecular weight. The fractions 
that comprised the CPS samples were compared to dextran standards, meaning 
that a 2000 kDa fraction was considered as having the same hydrodynamic volume 
as dextran with 2000 kDa as molecular weight (MW). The analyzed fractions 
throughout the text are identified as MW, although it represents an approximation. 
The different polymers derived from the CPS of Laffan and Wonderful cultivar 
mesocarp and exocarp (Figure 2) were composed of fractions with a similar MW, 
since no significant differences were found.  
 
Figure 2  An average composition of the four PPS samples derived from mesocarp and 
exocarp of Laffan and Wonderful cultivars (see Table 3).  
 
The polymers deriving from the Laffan and Wonderful cultivar mesocarp and 
exocarp were all characterized by a predominant fraction of about 2000 kDa, 
accounting for 75.4% of the total. The remaining 24.6% were comprised of five 
minor fractions, the most represented being: i) a fraction corresponding to a MW 
smaller than 410 kDa, and larger than 150 kDa (accounting for 7.4% of the total); 
 
152 
ii) a fraction having a MW smaller than 50 kDa, accounting for the 8.9% of the 
total. As expected, more variability was observed for the fractions having small 
MWs (much smaller than 50 kDa). 
Few reports are available to date on polysaccharide structure recovered from 
pomegranate fruit. A first report described a glucofructan extracted from the peel, 
having a molecular weight of 31 kDa and separated on a Sephadex G100 column 
(Khodzhaeva et al., 1984). Soni described a polysaccharide extracted from the 
rind of a non-specified variety, with a MW of 110 kDa determined by gel filtration 
on a Sephadex G200 and characterized by comparison with different dextrans 
(Jahfar et al., 2003). More recently, a glucomannan was extracted from the rind of 
a ripened pomegranate fruit and, by applying a similar analytical approach to that 
described by Sreelekha (2008), the authors determined its MW as 110 kDa (Joseph 
et al 2012). 
The present study determines for the first time the MW distribution of 
pomegranate polymers obtained from Laffan and Wonderful cultivars by using 
SEC. We demonstrate that CPS samples have similar MW distribution, in the 
same proportion for both cultivars and in the two parts of the fruit. The almost 
complete overlapping in the SEC profiles of the two cultivars is again in 
agreement with a previous work that suggested the Wonderful is derived from the 
more ancient cultivar, Laffan (Goor, 1967). 
Even if the most abundant fraction has a hydrodynamic volume corresponding to 
a dextran molecule of 2000 kDa, it must be taken into account that, in the present 
analysis, the possible branching of the polysaccharides can result in a 
hydrodynamic volume larger than the estimated MW. 
 
Gelling capacity of CPS 
The water-holding capacity of plant polysaccharides is determined by their 
chemical and structural properties and also by the pH and osmolality of the 
surrounding fluids (Eastwood et al.,1976). When expressed as water retained per 
gram of dried material, a range of 1.5 g water per gram of fiber for maize, to 23.7 
g water per gram of fiber for lettuce has been reported (Eastwood et al.,1976; 
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Connell, et al.,1974). It is well known that purified plant fibers such as 
carrageenan can form gels containing 99% water per gram of dried material 
(Eastwood et al.,1973). 
To the best of our knowledge, there are no data on the water absorption capacity 
of polysaccharides from pomegranate available to date. In this work a preliminary 
test was carried out on some representative CPS samples shown in Table 4, 
pointing out that the percentage of water adsorbed ranged from 98.6 to 99.1% 
of dried material.  
 
Samples 
Amount of CPS 
(g) 
% H2O 
CPS-mL 0.3 99.2 
CPS-mW 0.3 99 
CPS-eW 0.3 98.6 
Table 4. Gelling capacity evaluated as amount of adsorbed water by 300 mg of each CPS; 
data expressed as % on DM.  e= exocarp; m= Mesocarp; W = Wonderful; L= Laffan 
This confirms that these polymers are potential gelling agents in other fields such 
as food applications. These preliminary data help to improve our knowledge of 
the physical properties of polysaccharides recovered as typical by-products of the 
pomegranate fruit, and open future perspectives for adding value to this food 
waste. 
 
In vitro evaluation of prebiotic properties  
In this study the ability of B. breve B632 and L. plantarum L12 strains to use crude 
polysaccharides from pomegranate exocarp and mesocarp as the carbon source 
was investigated and compared to growth on glucose, i.e. an easily fermentable 
carbon source. Figure 3 shows that both strains could grow well on the CPS of 
Laffan and Wonderful mesocarp, being comparable to that of an easily 
fermentable carbon source such as glucose. Growth at 24 h on the Laffan variety 
was only 0.6 and 0.1 Log CFU/mL lower than that on glucose for L. plantarum 
L12 and B. breve B632, respectively. Growth at 24 h on the Wonderful variety 
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was 1.0 and 0.2 Log CFU/ml lower than that on glucose for the same strains. After 
the 24th h of incubation, both strains grown on glucose enter the stationary phase, 




Figure 3 . Evaluation of prebiotic properties of CPS from mesocarp of Laffan and 
Wonderful on the (a) L.planctarumPCS20 and (b) Bifidobacterium breve B632. 






However, the results shown in Figure 3 clearly indicate that CPS or the 
metabolites of their degradation are not toxic for the assayed strains and, on the 
contrary, are good growth substrates for them. Growth on the medium with no 
added carbon source reached only 1 Log CFU/mL increase at the 24th h compared 
to the beginning of incubation, thus showing that the m-MRS medium used in the 
experiments is a good one for performing prebiotic activity tests. 
 
Conclusions 
This study for the first time determines the MW distribution of  pomegranate 
polymers obtained from Laffan and Wonderful cultivars by using SEC. It has been 
demonstrated that CPS samples have a similar MW distribution for both the 
cultivars and the same distribution in the two parts of the fruit (mesocarp and 
exocarp). The almost complete overlapping of SEC profiles is in agreement with 
previous data that suggest that the Wonderful cultivar is derived from the more 
ancient cultivar, Laffan. 
The maximum extractive yield in terms of crude polysaccharides was 10% on 
dried mesocarp, achieved through water decoction for 60 min. The two varieties 
showed similar amounts, with the highest concentration in the mesocarp. In 
agreement with the literature, the use of hot water increases polysaccharide 
solubility and extractability and maximizes the recovery of CPS, while the same 
extraction at room temperature is always less efficient. These CPS were able to 
absorb up to 99.1% of water, confirming a potential use as gelling agents in food 
chemistry. On the whole, the prebiotic activity tests allow us to conclude that CPS 
from Laffan and Wonderful pomegranate cultivar mesocarp can sustain growth of 
beneficial and potentially probiotic bacteria such as those used in this study and, 
therefore, possess prebiotic properties. Growth of the Lactobacillus strain on the 
Laffan variety was higher than on the Wonderful one, whereas growth of the 
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